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Abstract  
 
For years, scientific research has availed itself of the opportunity of using animal 
models to understand the cellular and molecular mechanisms that regulate several 
human diseases. In this thesis, I showed the great importance to employ Drosophila 
melanogaster as model organism for the study of chronic diseases. Drosophila is 
considered an excellent and innovative model thanks to its peculiar characteristics such 
as low cost, small genome size, short generation time.  
About 75% of human disease-causing genes have functional homologs in Drosophila; 
furthermore, the fruit fly shows extreme genetic flexibility and a number of genetic 
systems has been developed to answer specific biological questions, such as the UAS-
GAL4 binary system that allows the expression of target genes in a tissue-specific 
manner.  
For all these reasons, Drosophila can be used for the study of different metabolic 
diseases among which obesity. In particular, in our laboratory we created a new 
Drosophila model of obesity that shows similar characteristics as those present in obese 
people, promoting an Adipose Tissue Macrophages infiltration (ATM) phenotype.  
Using this new model of obesity, I tried to understand the role of important compounds 
like Flavonoids and Anthocyanins, both considered anti-inflammatory and antioxidant 
agents, which regular consumption reduces the risk to develop metabolic disorders.  
Anthocyanins represent the major red, purple, and blu pigment in many plants and 
fruits. I have discovered that Anthocyanin are able to rescue the ATM phenotype by 
reducing the Drosophila hemocytes (similar to human macrophages) migration in the 
larval fat body, which carries out human adipose tissue and liver functions.  
Anthocyanins also show potential health benefits by reducing ROS levels, thus acting 
as antioxidant agents. This antioxidant activity may be due to the capacity to modulate 
the expression of some redox regulators like Glutathione-S-Transferase (GST) and the 
Nuclear factor erythroid 2-Related Factor 2 (NRF2).  
 
 
 
 
 
 
 
 
 
 
Riassunto 
 
La ricerca scientifica, da molti anni, si è avvalsa dell'opportunità di utilizzare diversi 
modelli animali per comprendere i meccanismi cellulari e molecolari che regolano le 
malattie umane. In questa tesi, ho dimostrato come Drosophila melanogaster, un 
eccellente organismo modello, svolge un ruolo fondamentale nello studio delle malattie 
croniche.  
Drosophila melanogaster è considerato un perfetto e innovativo modello animale 
poiché possiede alcune peculiari caratteristiche: bassi costi di mantenimento, 
dimensioni del genoma abbastanza piccole e un tempo di generazione breve; inoltre 
circa il 75% dei geni umani associati a malattie possiede un omologo funzionale in 
Drosophila.  
Il moscerino della frutta è infine un modello genetico estremamente manipolabile, e 
l’utilizzo del sistema binario UAS-GAL4 consente l'espressione di geni bersaglio in 
modo tessuto-specifico.  
Per tali motivi, Drosophila è ampiamente utilizzata nella ricerca biologica per lo studio 
di diverse malattie metaboliche tra cui l'obesità. In particolar modo, nel nostro 
laboratorio abbiamo utilizzato animali transgenici che rappresentano un modello 
innovativo di obesità, mostrando caratteristiche simili a quelle presenti in persone 
obese, in cui è stata stimolata l’infiltrazione di macrofagi nel tessuto adiposo per 
determinare il fenotipo ATM. Utilizzando questo innovativo modello di obesità, ho 
cercato di comprendere il ruolo svolto da importanti composti, i Flavonidi e le 
Antocianine, entrambi considerati agenti antinfiammatori e antiossidanti; sembra che 
il loro regolare consumo riduca il rischio di sviluppare malattie metaboliche. 
Le Antocianine rappresentano il principale pigmento rosso, viola e blu presente in 
molte piante e frutti. Gli esperimenti condotti con Drosophila melanogaster, con 
l’utilizzo delle Antocianine, hanno messo in evidenza il loro eccezionale potere 
antinfiammatorio, essendo in grado di ridurre la migrazione degli emociti (simili ai 
macrofagi umani) nei corpi grassi, tessuti che svolgono le stesse funzioni del fegato e 
del tessuto adiposo umano. Le Antocianine, in qualità di agenti antiossidanti, 
possiedono anche potenziali effetti benefici sulla salute riducendo i livelli di ROS; la 
loro probabile attività antiossidante potrebbe essere determinata dalla capacità di 
modulare l'espressione di alcuni geni codificanti per enzimi coinvolti in meccanismi 
di ossido-riduzione, come la Glutatione-S-Trasferasi (GST) e il Fattore di 
Trascrizione Nucleare Eritroide-2 (NRF2).  
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Chapter 1 
 
 
1. General introduction 
 
1.1 Drosophila melanogaster  
Drosophila melanogaster, commonly known as “fruit fly” is considered a powerful 
model organism for the study of fundamental biological processes.   
In 2000, Drosophila genome has been completely sequenced and has been found that, 
about 75% of human genes are conserved in Drosophila (1). 
Furthermore, Drosophila is an excellent model thanks to the small genome size, high 
fecundity, low cost, short generation time and a flexible genetic background. For all 
these advantages, the fruit fly can be used for studying of many human diseases as 
metabolic disorders, but also neurodegenerative diseases such as Alzheimer, 
Parkinson and Huntington. 
 
 
1.1.1 Drosophila life cycle 
Probably, the best advantage of this model system is the short life cycle. This is 
temperature-dependent and requires about 10 days at 25° C from the egg to the adult 
fly. The life cycle consists of four distinct stages: egg, larva, pupa, and adult 
(Fig.1.1). Virgin females and males are placed in vials, within a few hours can lay 
many eggs, after 24 hours laying the eggs hatch into 1st instar larvae. The larval stage 
of this insect consists of three instars (5 days), during which the larva loses its 
spiracles, mouth, and hooks. At the fifth day after egg laying (d AEL), the larva 
encapsulates itself inside in a protective colored puparium and begins the pupariation 
process, where it happens metamorphosis, giving rise to the adult fly. During the 
pupal stage, the steroid hormone Ecdysone determines degeneration of all organs, a 
process called histolysis, to restructure them into the adult shapes. At 10 days from 
fertilization the eclosion process takes place, where the adult flies emerge through the 
operculum. Finally, sexual maturity is acquired in about 8–12 hr (2). 
  
2 
 
 
Fig. 1.1 Life cycle of Drosophila melanogaster. Drosophila life cycle consists of four distinct stages: egg, larva, 
pupa, and adult. This process is temperature-dependent; the flies are cultured in vials and are kept at 25°C to obtain 
adults after 10 days (Hales et al., 2015). 
 
 
1.1.2 Regulation of growth by ecdysone 
Ecdysone is a steroid hormone produced by the prothoracic gland (PG) Fig 1.2 (A) 
and released into the hemolymph.  
 
Fig. 1.2 A. prothoracic gland B. endocrine system in the larvae and adult. 
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Ecdysone controls animal growth and maturation since it is released from the PG 
right before the change of each instar by a complex mechanism that involves the 
coordination of secreted factors from the fat body and the presence of nutrients in 
the food (Fig.1.3). 
 
Figure 1. 3 Coordination between ecdysone, fat body, nutrients and molting during larval growth and 
maturation to pupa (modify from T. M. Lab, «The regulation of body and organ size). 
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1.1.2 UAS-GAL4 system 
The UAS-GAL4 binary system is a method to induce gene expression, primarily 
used in Drosophila, although it has also been applied to mice and zebrafish. This 
powerful genetic technique has been developed by Andrea Brand and Norbert 
Perrimon in 1993. The UAS-GAL4 is a binary system that allows the ectopic 
expression of a transgene in a specific tissue and it consists of two components: the 
first is a construct that presents a “driver” that induces the expression of the 
transcription factor GAL4, normally expressed in yeast; the second is a construct 
where the transgene of interest is placed downstream of a promoter sequence 
called UAS (Upstream Activation Sequence), that consists of GAL4-binding 
domains (Fig 1.4) (3). 
The great advantage to use Drosophila as a model to regulate the expression of 
specific genes is that the flies does not express an endogenous GAL4; in this way, 
the off-target effects are minimal. Furthermore, the transgene is only expressed 
when the two constructs are co-present in the F1 generation (2, 4).  
 
 
 
Fig. 1.4 UAS-GAL4 system. A tissue-specific promoter drives the expression of the transcription factor GAL4 that 
it binds the UAS sequence and allows the expression of the gene of interest. (from Daniel St Johnston Nature 
Reviews Genetics (2002) volume3, pages176–188). 
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Chapter 2 
 
2.1 General introduction on Obesity in vertebrates 
 
2.1.1 Obesity 
Obesity is defined a metabolic syndrome widely spread worldwide, often associated 
with other chronic diseases such as cardiovascular disorders, type II diabetes and 
cancer (5).  
Obesity is a public health concern, and the World Health Organization estimates that 
1.9 billion adults are overweight (BMI > 25 kg/m2), among which 600 million are 
obese (BMI > 30 kg/m2) (Fig. 2.1). Based on data reported by the World Health 
Organization (WHO), the incidence of obesity continues dramatically to grow in 
specific countries, in particular in developed and developing countries like USA, 
Europe and United Arab Emirates. The onset of obesity is the result of multifactorial 
elements, including genetic predisposition to obesity and subsequently, the impact 
of several environmental factors like sedentary lifestyle and diet rich in fat and sugar 
and poor in phytonutrients (6, 7). 
 
 
Fig. 2.1 Percent of population with obesity. Obesity rate spread in worldwide from 1980 to 2015. (ANDREW 
JACOBS and MATT RICHTEL for The New York Times SEPT. 16, 2017).  
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2.1.2 Causes that influence the insurgency of Obesity  
 
Although obesity has been associated mostly with an excess of food intake many 
other factors are known to influence its insurgency like: 
- genetics like for rare monogenic forms in many components of the 
leptin-melanocortin axis (8) (Fig. 2.2); 
- bad habits, like lack of day-night circadian sleep;  
- environmental factors like Bisphenol A that affected fatty acids synthesis; 
- health disparities in USA is higher among Afro-Americans and Native 
Americans; 
- epigenetics changes, one of the most relevant evidence that supports this 
hypothesis has been reported in the bio-sociological analysis performed on the F1 
generation from women who were pregnant during 1944 famine in the Netherlands, 
known as the Dutch Hunger Winter. Those women had children and grandchildren 
who were unusually small or prone to diabetes and obesity (9). 
 
 
Fig. 2.2 Leptin-Melanocortin system of energy balance (Ranadive, 2008). 
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2.1.3 Obesity and inflammation 
The “obesity state” triggers a low-grade chronic inflammation in metabolically 
active sites such as liver and adipose tissue (10, 11).  
The inflammation is a defense process, which comprises a series of cellular and 
humoral reactions with the aim to protect the organism from various insults among 
which infection and tissue damage leading to the rescue of the affected tissue (12, 
13). In normal conditions, the adipose tissue regulates the storing energy reserves in 
the form of triglycerides, however it also has an important functions as an endocrine 
organ, producing a variety of pro-inflammatory cytokines such as interleukin (IL-1, 
IL-6, IL-8), interferon γ (IFNγ) and tumor necrosis factor α (TNFα) (14, 15). In the 
adipose tissue of obese people, the production of these molecules by adipocytes, is 
abnormal and induces a low level of chronic inflammation that influences other 
systems by altering their functions (16) (Fig. 2.3). Furthermore, the obese adipose 
tissue diminishes its capability to store fats, leading to an increase of circulating 
free fatty acids (FFAs) that is thaught to promote insulin resistance and damage to 
the mitochondrial membrane enhancing oxidative stress caused by ROS  release (17-
19). 
The role of the inflammatory response is to combat infection and tissue injury 
through the activation of the innate immune system with recruitment of the immune 
cells, the mammalian macrophages. The principal role of macrophages is host 
defense against pathogens through their phagocytic activity, but they show also other 
important functions such as homeostasis, inflammation and repair processes (20).  
Once active, the macrophages infiltrate the adipose tissue and release further 
molecules such as NO, TNF-α, IL-6, IL-1 by increasing the serum FFA and 
triglyceride levels (21). 
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Fig. 2.3 Different mTOR levels in normal and obesity conditions. In physiological condition, the leptin and 
several stimuli activate the mTOR pathway contributing to the maintenance of the metabolic homeostasis, while in 
obese condition mTOR is overexpressed facilitating the accumulation of inflammatory cells (Matarese, Procaccini, 
& De Rosa, 2012). 
 
2.1.4 Obesity and oxidative stress 
In obese people, lipid accumulation and chronic inflammation increase oxidative 
stress with the production of high levels of reactive oxygen species (ROS) (22, 23). 
ROS are produced during mitochondrial electron transport, where the reduction of 
oxygen through the addition of electrons leads to the formation of different ROS 
species including free radicals such as superoxide anions (O2
-) hydroxyl (HO), 
perhydroxy (HO2
-) and alkoxy (RO) and non-radicals like hydrogen peroxide (H2O2) 
and molecular oxygen (O2) (24). 
In mammals, elevated ROS alterate physiological function of cellular processes 
throught damage of DNA, proteins and lipids. 
ROS can interact with DNA causing modification of the nucleotide structure, 
triggering mutations and genomic instability, they can also oxidize proteins, this 
modifications result in changes in structure compromising biological functions, 
finally they can react with the polyunsaturated fatty acids of the membranes, causing 
cell death (24-26). 
All this events can lead to many human pathologies including cancer, 
neurodegenerative disorders, cardiovascular disease, diabetes and aging. Despite 
their well-known toxic effects, it seems that at low concentrations they are involved 
in cellular signaling and defense against environmental insults (24).  
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In order to prevent excess ROS, the mammalian cells are equipped with defence 
mechanisms that comprise antioxidative compounds such as enzyme, phenolic 
compounds, vitamins and drugs, they are reducing agents able to counteract 
oxidative species formation. The enzymatic part regards the endogenous antioxidant 
activity and includes Catalase, Superoxide dismutase, Glutathione-S-Transferase 
(GST), while exogenous antioxidative compounds are vitamins A, C, E and phenolic 
compounds like Anthocyanins (27, 28).  
 
2.1.5 Signaling pathways relevant in obesity 
 
JNK pathway 
The excessive production of ROS determinates the activation of the c-Jun-NH2-
terminal kinase (JNK), member of a mitogen-activated protein kinases (MAPKs) 
[15].  
MAPK cascade consists of four major component: c-Jun N-terminal kinases (JNK), 
p38 kinase (p38), the extracellular signal-related kinases (Erk1/2) and kinase Erk5 
(29). 
These kinases are evolutionarily conserved in eukaryotes and show a key role in 
cellular processes in response to a wide variety of signals among which growth 
factors, hormones, cytokines and reactive species. In particular, JNK signaling 
pathway is involved in few biological processes such as inflammation, cell 
proliferation, differentiation and apoptosis (24).                                        
Activation of JNK can be determined by stress, inflammatory cytokines and growth 
factors and requires a cascade of phosphorylation events starting with the activation 
of the JNKKK kinases, such as ASK1, TAK1, that activate the JNKK as MKK4 and 
MKK7 (30). 
In mammals, three JNK genes have been identified (JNK 1, 2, 3) with at least 10 
different splicing isoforms. Regarding JNK 1 and 2, their expression occurs in every 
cell and tissue type, whereas JNK 3 is selectively expressed in the brain, heart and 
testis (31, 32).  
 
GST (Glutathione-S-Transferase) 
GST is one of the most efficient detoxifying enzymes, found mainly in the cytosol. 
The main biological roles of GST include detoxification and protection against 
oxidative stress by catalyzing the conjugation of electrophilic substrates to 
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glutathione (GSH), obtaining products no longer reactive and more soluble that can 
be eliminated from the organism. Over to detoxifying activity, GST presents other 
important functions: it can inhibit the activity of JNK by causing the block of 
apoptosis and promoting cell proliferation and tumor growth (33).  
GSTs existing in mammals, are generally divided into three categories: cytosolic, 
microsomal, and mitochondrial. Up to now, seven classes of mammalian cytosolic 
GSTs have been identified: Alpha, Mu, Pi, Theta, Omega, Sigma and Zeta (34, 35). 
 
NRF2 
The nuclear factor erythroid 2-related factor 2 (NRF2) is considered one of the main 
regulators of the intracellular antioxidant response both in vertebrates and 
invertrebrates. NRF2 is a member of cap’n’collar (CNC) leucine zipper (bZIP) 
family of transcription factors and it is expressed in all cell types (36).  
NFR2 is a master of redox response, but recent studies have identified other 
numerous functions, for example, NRF2 regulates lifespan extension by caloric 
restriction and it seems to prevent cancer in animal models, although in humans a 
costitutive NFR2 activation is linked to greater incidence of cancer (37-39). 
]. Studies performed in mice and human cultured cells have shown that upon 
exposure to oxidative stress and electrophilic chemical insults, Nrf2 activity 
increases. Experiments in animal models have demonstrated that, once activated, 
NRF2 translocates to the nucleus and binds the Musculo-Aponeurotic Fibrosarcoma 
oncoprotein (Maf). The NRF2/Maf dimer regulates the expression of over 200 
genes, containing antioxidant response elements (AREs), by promoting up-
regulation of few redox regulators among which Glutathione S-transferase, 
Thioredoxin, Peroxyredoxins, NAD(P)H quinone oxidase 1 (NQO1) and Heme 
oxygenase 1(HO1) (40, 41). 
In this way, NRF2 regulates many cellular responses such as homeostasis, 
proliferation, autophagy, DNA repair, and mitochondrial physiology. Under non-
stressed conditions, NRF2 protein levels are kept low through its proteasomal 
degradation. Three E3 ubiquitin ligase complexes control the ubiquitylation and 
proteasomal degradation of NRF2: Kelch-like erythroid CNC homologue (ECH)-
associated protein 1 (KEAP1), SKP1 and HRD1 (42).  
In particular, the inhibition of NRF2 is orchestrated by its cytoplasmatic negative 
regulator, Keap1, associated with Cul3-based ubiquitinligase system (43, 44).  
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The inhibitory effect of Keap1 involves the supression of NRF2 activity in the 
cytoplasm becoming target for proteosomal degradation. Furthermore, Keap 1 can 
function as a redox sensor because its cysteine residues, indeed in a stress condition, 
the oxidants bind these residues determining the disassociation between Keap 1and 
NRF2 and preventing Nrf2 ubiquitination and proteolysis by Keap1(38).  
 
2.1.6 Obesity and cancer 
Recent data have expanded the consistent evidence that connects obesity to an 
increased risk of some cancers (45, 46). 
Despite the limitations, many possible mechanisms exist that explain the obesity-
cancer link by regarding studies performed on insulin, insulin-like growth factors 
(IGFs), sex hormones, and adipokines, but other candidate process are inflammation 
and oxidative stress (47). 
In vitro and in vivo studies have shown that insulin and insulin-like growth factor 1 
(IGF-1) are connected to obesity. It has been hypothesized that hyperinsulinemia 
causes the activation of insulin and IGFs pathway, these events determine a block of 
the apoptotic process and promote tumor growth in the colon, kidney, prostate, and 
endometrium (48-50). 
Another evidence of a possible relationship between obesity and cancer has been 
found with sex hormones; in fact, they trigger cell division by promoting tumor 
progression. In particular, breast, uterine and prostate cancers are caused by sex 
steroid hormones activities (49, 51).  
Reaserches performed on Adipokines, in particular on leptin, have suggested as this 
hormone is able to have a negative role in the development of different cancers, such 
as endometrial, breast, colon, and prostate cancer (52, 53).  
Numerous cohort studies have reported that people who are overweight or obese are 
more likely to develop some cancers than normal-weight people including 
endometrial, breast, tyroid, liver, kidney and ovarian cancer (54-59). 
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2.1.7 Animal models to study obesity and related pathologies  
 
As already mentioned before, obesity is an epidemic problem, and it is associated 
with several health problems, including diabetes, cardiovascular disease and cancer. 
The precise molecular mechanisms that link obesity to these health problems are not 
yet clear. To better understand the etiology of metabolic disorders, specific animal 
models have been obtained that present all the complications linked to the human 
disease. Below are reported some animal models associated with obesity-related 
pathology (60).  
 
Most used mouse obese genetic models: 
The agouti mutation was first reported among the several obese mice used in 
research and it has become the first obesity gene characterized at the molecular level 
(61).  
Agouti is a gene that controls the distribution of the red/yellow pigment melanin in 
mammal hairs, in particular the lethal yellow mutant mouse (Ay) is a dominat 
mutation in the agouti locus and it has been considered a good obesity model. (Ay) 
mutation exhibits a typic obese phenotype associated with hyperinsulinemia, insulin 
resistance, hyperglycemia and hyperleptinemia; furthermore, agouti overexpression 
in the adipose tissue induces fat increase without alteration of food intake (62, 63). 
 
In 1994, Zhang et al. have discovered that mutation in leptin gene caused mutation 
in the mouse gene obese (ob) (Fig. 2.4) (64). Leptin is a hormone secreted by 
adipocytes, in normal condition leptin induces a reduction in body weight, food 
intake and serum insulin, instead the mutation exhibits obesity, type 2 diabetes and 
insuline resistance, therefore leptin is considered a marker of obesity (65). 
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Figure 2.4 The ob/ob mouse (right) and wt mouse (from Zhang Nature 1994 vol 372 1 Dec 425-32) 
 
Another type of obese model is LepRdb/db mouse; this time the mutation regards  
leptin-receptor gene, the metabolic profile leads to hyperphagia and obesity, with 
consequent hyperleptinemia and insulin resistance (66, 67). 
 
Also a high-fat diet (HFD) model is used for studying the obese phenotype. Different 
mouse strains respond to HFD-induced obesity; in particular, the C57BL/6J strain 
shows similar characteristics to obese people when fed with HFD, which 
corresponds to a typical diet containing 45% of calories from lipids, the same diet 
used in developed countries (68). 
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2.2 General introduction on obesity in Drosophila 
 
2.2.1 Obesity and inflammation in Drosophila 
Obesity is defined a metabolic syndrome that affects all age and each kind of social 
class, the last data published by WHO reveal that obesity is one of today’s most 
public health problems.   
Obesity is determinated by excessive fat accumulation in adipose tissue that presents 
a risk to health. That pathologic condition stimulates the activation and release of 
inflammatory mediators such as TNFα and IL-6, promoting an inflammatory process 
and subsequently oxidative stress (69-72). 
The inflammatory state induces activation of the innate immune system with 
recruitment of the immune cells, the mammalian macrophages, while in Drosophila 
it is orchestrated by hemocytes, circulating cells in the hemolymph, present at all 
stages of the life cycle and representing the fly’s innate immune system.  
The Drosophila hemocytes infiltrate the fat body, considered equivalent to the 
mammalian liver and adipose tissue, and in turn release more inflammatory 
mediators among which the TNF-α ortholog Eiger, to promote the ATM phenotype 
(71, 73). 
 
The Hemocytes 
In Drosophila melanogaster, the hemocytes, motile and phagocytic cells are 
produced in the limph gland, an hematopoietic organ and subsequently stored in 
specific sites called Hematopoietic Pockets located between epidermis and muscle 
layers (74). 
In Drosophila are present three different cell types of hemocytes are present with 
slightly different functions: 
-Plasmatocytes represent the majority of circulating hemocytes during the larval 
stage (∼95%), they show phagocytic activity like mammalian macrophages, indeed 
these cells are able to migrate to sites of infection through of the protusions of actin-
rich filopodia and lamellipodia (75). 
-Lamellocytes represent about 2,5% of total hemocytes, they are rarely present in 
larva, however these particular cells are required in case of invasion by endoparasites 
in which they are involved in pathogen encapsulation (76). 
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-Crystal cells represent the remaining 2,5% of total hemocytes, they are released 
during pupariation phase, they are characterized by the presence of cytoplasmatic 
crystal-like inclusions; they secreted specif enzymes required for the melanization 
cascade (77). 
It seems that, in response to injury or infection, the sessile hemocytes start to migrate 
to the damaged site and promote the phagocytic activity, but the specific signal that 
triggers the switch from sessile to mobile cells is still not known.  
A recent work has hypothesized that hemocytes migration is linked to ecdysone 
activity (75). 
 
The Fat body  
The human adipose tissue regulates the homeostatic metabolism, it provides an 
energy storage in form of TAG, deposited in specific cells called adipocytes. During 
starvation, the lipases break TAGs down into free fatty acids (FFAs) that are released 
in the bloodstream to produce energy (Fig. 2.5) (78, 79).  
Furthermore, the adipose tissue is also an endocrine organ, it produces several 
adipokines like leptin and adiponectin. The insect fat body is an organ analogue to 
vertebrate adipose tissue and liver, it is considered a multifunctional organ, indeed 
it regulates nutrient storage and energy metabolism, it coordinates insect growth with 
metamorphosis, it also carries out an exocrine fuction by producing several 
antimicrobial peptides (80). 
 
Figure 2.5 Photographs of larval fat body from wt animals A nuclei are stained with blue 
 
16 
 
Regarding the storage function, the fat body is fundamental for the life of insects, 
the energy in form of TAG is stored in adipocyte cells, characterized by the presence 
of numerous organelles called lipid droplets with metabolic activity.  
The lipolytic activity includes two lipases: Brummer and Triglyceride lipase. The 
metabolic functions conducted by the fat body are regulated by hormonal signals 
such as insulin and ecdysone. During insect metamorphosis, the fat body undergoes 
to a “remodeling” process that consists in a destruction of larval tissues and 
concurrently the determination of adult tissues (81). 
All this information indicates that Drosophila shares with mammals the same 
mechanisms of storage and mobilization of energy, so this insect becomes an 
excellent model to study lipid homeostasis (82). 
 
 
2.2.2 Obesity and oxidative stress in Drosophila 
 
In humans, the relationship between obesity and ROS production is still very 
controversial because many problems occur while using genetic models for this 
metabolic disease. However, it is very important to remember that the signals that 
trigger the increase of ROS level are highly conserved in mammals and flies, and 
this allows using Drosophila as a genetic model to analyse and find novel pathways 
involved in obesity and in other metabolic disorders. ROS production can be induced 
by different signals such as proinflammatory cytokines, UV light, radiation and 
environmental toxins (83). 
Also in Drosophila, ROS perform an essential role in maintaining homeostasis by 
triggering cellular signaling pathways and host defense mechanisms (24).  
Nevertheless, an excessive production of ROS causes an intracellular imbalance and 
determinates irreversible oxidative damage to DNA, proteins and lipids (84).  
This cell dysfunction lead to severe complications and increases the risk to develop 
diseases such as diabetes, neurodegeneration, cancer and aging (85). 
Fleming and colleagues have demonstrated that oxidative damage regulate the 
lifespan in Drosophila both in normal and stress conditions (86). 
Another work showed that unrepaired damages caused by free radicals provoke 
aging and death in Drosophila (87). 
As mentioned previously, in humans but also in Drosophila, cellular defense 
mechanisms against oxidative stress include enzymatic components like Glutathione 
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reductase (GSR), Glutathione peroxidase (GPx) and GST, and non-enzymatic 
components as vitamins and polyphenolic compounds (83). 
Further data have shown that dietary antioxidants like vitamins and polyphenols 
ameliorate the effects of oxidative stress induced by paraquat. In Drosophila 
lifespan, in particular, it has been observed a sexual dimorphism, with females 
exhibiting an increase in lifespan compared to males (88-90).  
 
 
 
 
 
 
2.2.3 Signaling pathways relevant in obesity conserved in Drosophila 
 
The TNF-α orthologue Eiger 
TNF-α belongs to a superfamily of TNF/TNFR, the name “Tumor Necrosis Factor” 
derives from its identification in hemorragic necrosis of human tumors caused by 
endotoxins (91).  
In mammals TNF-α is considered an inflammatory mediator, it promotes the 
production of prostaglandins and other cytokines.  
Furthermore, it was also reported that TNF-α is able to promote macrophages 
differentiation, proliferation and to induce programmed cell death (92, 93). 
In Drosophila, TNF-α ortholog Eiger shows similar functions, it is a regulator of the 
death signal, indeed it can induce cell death by activating the JNK pathway, 
furthermore Eiger is required for innate immune response against extracellular 
pathogens (94, 95). 
 
The JNK orthologue Basket 
JNK homolog, Basket in Drosophila 
Similar to mammals, the JNK pathway is highly conserved in Drosophila, though 
only one JNK isoform exists in Drosophila, Basket, whereas ten JNK isoforms are 
found in mammals (96). 
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Figure 2.6 The JNK signaling pathway (modified from Valenza et al, BMRI 2018). 
  
Thanks to low gene redundancy, Drosophila becomes an amazing model system to 
study JNK regulation in normal and stress conditions. ROS-induced signaling 
pathways include the activation of JNK, this event consists of a cascade of 
phosphorylation events starting with the activation of the JNKKK kinases, 
consisting of the Ask1 and Tak1, that activate MKK7, the ortholog of Hemipterous 
(Hep), and terminates with the activatioPn of the JNK kinase, encoded by the basket 
(bsk) gene in Drosophila, that is negatively regulated by Puckered (uc), a 
phosphatase, a target itself of the JNK kinase (Fig. 2.6) (97, 98).  
In Drosophila, JNK protects the cells from oxidative stress and is able to extend 
lifespan in adult flies through the activation of autophagy, in particular JNK 
regulates the expression of Atg9, a component of the autophagy complex (99). 
 
GST D1 
As already mentioned above, GSTs existing in mammals, are generally divided into 
three categories: cytosolic, microsomal, and mitochondrial. Up to now, seven classes 
of mammalian cytosolic GSTs have been identified: Alpha, Mu, Pi, Theta, Omega, 
Sigma and Zeta (34, 35). 
In D. melanogaster, the last four classes are present plus other two members, Delta 
and Epsilon, considered the most common classes of GST. In particular, in the last 
years, the Delta class is the best studied (100, 101).  
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Recently, it was reported that, four spliceforms of the Delta class of GST, like GST 
D1, D2, D3, D4, regulate in different manners JNK activity. GST D1 seems to inhibit 
JNK activity, whereas the other three isoforms activate it (102).  
 
CncC orthologue of NRF2 
The Drosophila CncC, ortholog to the vertebrate Nrf2, is a transcriptional factor, it 
is considered an important regulator of the cellular redox state both in vertebrate and 
Drosophila, whereas Keap1 is its negative regulator (103). 
In normal conditions, CncC is normally present at the cytoplasmatic level, 
sequestered by its inhibitor Keap1, that induces CncC degradation throught 
ubiquitylation, but in conditions of elevated ROS, CncC is free to translocate into 
the nucleus, bind the Antioxidant Response Element (ARE) and induce the 
expression of key factors in the antioxidant processes like GST D1 (37, 104-106). 
Previous studies have identified a number of reactive Cys residues in Keap1 which 
correspond to the sites of attack by ROS, in this way CncC is disassociated by Keap1 
and can regulate the expression of target genes (106).  
Although Drosophila is a well-known model for aging, the knowledge on NRF2 
signaling is still not clear. Bohmann and Sykiotis have demonstrated that Drosophila 
CncC/Keap1 show function similar to human NRF2/Keap1; furthermore, they have 
shown that NRF2 pathway is involved in several cellular responses, it induces the 
expression of antioxidant enzymes like GSTD1, it is able to balance the intracellular 
redox, finally it regulates intestinal stem cell proliferation by reducing the age-
related degeneration at the intestinal level. 
 
2.2.4 Obesity and cancer in Drosophila 
 
In the last years, the common fruit fly Drosophila melanogaster has become a 
predominal model system to study molecular mechanisms of human disease 
including cancer (46). Furthermore, up to 75% of  human  disease-causing  genes  
have  functional homolog in Drosophila (1) .                                                                                                           
The molecular mechanisms that regulate growth, differentiation and metabolism are 
highly conserved in mammals and Drosophila, but the fruit flies have a genome less 
redundant than human genome, this allows simplifying genetic analyses for studying 
different human diseases. In particular, Drosophila is considered a cancer research 
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model with a focus on the roles of hemocytes to explain the interplay between 
inflammation and cancer (107).  
Rudolf Virchow observed for the first time that leukocytes were associated with the 
neoplastic tissue by providing an evident link between cancer and inflammation. 
Subsequently, numerous experiments have been performed to convalided this 
discovery. Trincheri et al. proposed a possible connection of the inflammatory lesion 
that triggers cancer(108). Furthermore, it has been well-reported that the 
inflammatory process promotes tumor progression; in particular, it has been revealed 
that macrophages may be involved in cancer initiation or prevention (109, 110).                                                                         
To better understand the real role of hemocytes in tumor progression or regression, 
several studies have been performed by using Drosophila as a tumor model: for 
example, Pastor-Pareja and colleagues have demonstrated through an innovative 
cancer model that a relationship exists between tumor and hemocytes (111). 
Research in Drosophila has documented the possible protagonists involved in the 
interactions between cancer and inflammation by including the JAK/STAT, JNK, 
TNF, Toll/Imd/TLR signaling pathways (112).                                                                        
Thanks to these tools, Drosophila can be useful as a tumor model system to discover 
many signaling pathways conserved both in Drosophila and humans that regulates 
the immune system and its interactions with tumor cells. 
 
2.2.5 Drosophila models to study obesity 
 
Recently, Drosophila melanogaster has emerged as a powerful model organism to 
investigate the genetic mechanisms linked to obesity and other human metabolic 
disorders, because most of the human metabolic processes are conserved in flies. 
Furthermore, mammalian liver and adipose tissue show functionally analogies with 
the fly’s fat body, considered a dynamic tissue involved in multiple metabolic 
functions like to store and release energy in the form of lipids and glycogen (113). 
Here we report, two Drosophila established models used to study the metabolic 
changes and to chararcterize obesity-associated disorders. 
1- HFD (High-Fat Diet) model consists of flies grown on specific diet enriched 
with 30% coconut oil as a source of saturated fatty acid that has been shown to cause 
a phenotype similar to obesity in humans, indeed HFD-induced obesity in flies show 
an increased triglyceride and glucose levels, resistance to starvation but at the same 
time this diet decreased lifespan, altering the positive intake of energy balance.  
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Recent publications report that HFD model in Drosophila causes heart dysfunction, 
typically found also in obese people (114, 115). 
2- Genetic models, by genetic reduction of a key enzyme necessary for of energy 
storage, Brummer lipase1 (Bmm1). The Bmm gene encodes for a lipase, homologue 
of the human adipocyte triglyceride lipase (ATGL), that determinates the lipolysis 
of TAG stored in lipid droplets in adipose tissue. The lack or malfunction of Bmm 
activity induces a deregulation of energy stored causing the obesity in flies. In Bmm 
mutants the animal continues to store energy but is not able to mobilize TAGs (116). 
 
 
2.3 Anthocyanins 
 
During my PhD project, I investigated the function of bioactive food like Flavonoids 
polyphenolic compounds, found in fruits and vegetables, components regularly 
present in human dietary, that have been recognized to possess a protective action 
against obesity and ATM phenotype, due to their anti-inflammatory and antioxidant 
activity. Over to these proprierties, they also show anti-diabetic, anti-cancer, anti-
aging effects (117-121).  
Until now, more than 9000 flavonoids have been identified in plants (122). 
Flavonoids biosynthesis genes are conserved among various species and they are 
synthesized through the combination of aromatic amino acids like phenylalanine and 
tyrosin that linked with acetate units (123). 
The basic flavonoids structure is characterized by two benzene rings linked throught 
an oxygen-containing pyrene ring, with several costituents that allow subdividing 
them into different classes among which Flavonols, Flavonones, Flavanols, 
Flavones, Isoflavones and Anthocyanins (Fig. 2.7) (124). 
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Fig. 2.7 Chemical structures of Flavonoids. The basic structure is constituited by three different heterocycle rings, 
thus that Flavonoids can be divided into six major subclasses: flavonols, flavanones, flavanols, flavones, anthocyanins 
and isoflavones (Pandey KB et al., 2009). 
 
Anthocyanins’s activity 
In particular, the study has been focused on one class of flavonoids, Anthocyanins. 
Anthocyanins are the red, purple and blue pigments found in flowers and the fruits 
of many plants. Recent studies have demonstrated that Anthocyanins-rich dietary 
reduces the risk to develop chronic diseases such as diabetes, obesity, cancer and 
cardiovascular diseases (125-127). 
For what concerns the antidiabetic effect of Anthocyanins, it has been widely 
demonstrated that these bioactive molecules are able to increase insulin secretion in 
humans (128). 
Furthermore recent studies, performed on model of diabetic mice, have reported that 
Anthocyanins ameliorate hyperglycemia and insulin sensitivity via adenosine 
monophosphate-activated protein kinase (AMPK) activation in adispose tissue and 
liver (129). 
Anthocyanins also show anti-obesity proprierties. Clinical studies in humans have 
demonstrated that an higher consumption of anthocyanins, is associated with weight 
loss in both men and women (130, 131).  
In addition they prevent weight gain and reduce the fat accumulation in obese mice 
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under High Fat Diet condition and in C57BL/6 obese mice (132-135). 
Interestlingly, in our Drosophila model of obesity (described below), we find that 
anthocyanins ameliorate the obese phenotype by reducing the hemocytes migration 
and accumulation and phagocytic activity in larval fat body (136). 
How Anthocyanins rescue the obese phenotype is still not clear, of course they act 
on inflammatory and oxidant processes. 
The possible anti-inflammatory mechanism of anthocyanins, may include the 
inhibition of a several pro-inflammatory mediators like the nuclear factor-κB (NF-
κB), Relish in Drosophila that, in response to external stimuli like oxidative stress 
and inflammation, triggers a large signaling cascade that culminates with the 
upregulation of proinflammatory cytokines/chemokines including TNF-α, IL-6, IL-
1, IFN-γ, IL-8, the inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 
(COX-2). At the same time, the anthocyanins are able to act concomitantly with 
detoxification enzymes such as superoxide dismutase, catalase, glutathione 
peroxidase, GST, and glutathione reductase to reduce oxidation and activate 
antioxidant detoxifycation factors such as NRF2 called CncC in Drosophila (121, 
137).  
These finding suggest that anthocyanins can regulate the inflammatory responses, 
therefore they can be considered of the anti-inflammatory agents. 
 
Many studies performed in animal models have demonstrated that Anthocyanins are 
also considered potential anticancer agents. 
Anthocyanins have been isolated for investigating their anticancer proprierties on 
several tissues and organs like esophagus, colon, breast, liver and prostate (138). 
Using mouse models, it has been discovered that Anthocyanins are able to inhibit 
angiogenesis and induce apoptosis and they possess anti-invasive proprierties by 
inhibiting the JNK pathway and Akt/mTOR signaling (139, 140). 
 
Epidemiological studies show the link between Anthocyanin-rich diet and 
cardiovascular diseases. In vitro studies have demonstrated that Anthocyanins show 
anti-thrombotic effects, also observed in rats, in which Anthocyanins intake reduces 
the infarct size and modulates the antioxidant response by increasing the myocardial 
glutathione levels (141, 142).  
Altogether, these studies confirm the beneficial effects on health of Anthocyanins. 
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2.4 Drosophila P0206-Gal; UAS-Ni obesity model 
 
In this thesis, i focused on anti-inflammatory and antioxidant activity of 
Anthocyanins using a new Drosophila model of obesity. 
In order to obtain this new model of obesity, we genetically reduced the size of the 
prothoracic gland, the endocrine organ, that produces the ecdysone hormone, that 
plays essential roles in coordinating developmental transitions such as larval molting 
and metamorphosis (143). 
The genetic manipulation of the prothoracic gland causes the reduction of ecdysone 
levels (E74b target gene), resulting in block of the development, indeed the animal 
does not complete the cycle, it remains at third larva instar and continues to feed for 
3 weeks with an increased in body weight (Fig. 2.8 A-B). 
Furthermore, Drosophila fat body functions as storage for nutrients, which regulates 
the storage and release of energy in response to demand, whereas in an obesity 
condition the fat body continues to accumulate fat and sugars, indeed in our obese 
animals we observed that the size of the fat body cells from P0206-Gal4; UAS-Ni 
larvae increased (Fig. 2.8 C) also due to the accumulation of fats in lipid droplets 
visible by Nile Red staining (Fig. 2.8 D) (136).  
In this way, P0206-Gal4; UAS-Ni animals acquired a phenotype that resembles to 
that seen in obese people, among which increased TAGs and glucose levels 
circulating in the hemolymph. 
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Figure 2.8 New Drosophila obese model. (A) the reduction of the prothoracic gland’s causes the block of the 
puparation, (B)this event determinates the reduction of ecdysone levels in P0206-Gal4; UAS-Ni animals, (C) the size 
of fat body cells in P0206-Gal4; UAS-Ni animals increased, indeed through (D) Nile Red staining is possible to 
observe the accumulation of lipids in larval fat body. 
 
 
Throught the binary system UAS-Gal4, we used P0206-Gal4 driver for prothoracic 
gland-targeted RNA interference (RNAi) silencing the expression of CG7839 gene, 
ortholog of yeast Nok1, a ribosomial component, UAS-Ni (144). 
In these conditions we blocked pupariation creating larvae P0206-Gal4; UAS-Ni 
with obese phenotype in the F1 generation (Fig. 2.9). 
 
 
Figure 2.9 P0206-Gal; UAS-Ni offspring. In our model, we obtained the reduction of ecdysone production 
through the binary system UAS-Gal4 by regulating the expression of UAS-Ni (ortholog of yeast Noc1) in 
the prothoracic gland (using P0206-Gal4) obtaining larvae with similar features observed in obese people. 
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Moreover, in our Drosophila model hemocyte infiltration increases in larval fat 
recalled by pro-inflammatory cytochines. During this inflammatory state, hemocytes 
surround the fat cells, mimicking a process described in the fat of obese individuals 
suffering from chronic inflammation. Furthermore, these animals exhibit significant 
increase in ROS production over time, indicating the presence of an oxidative stress 
that may be responsible for the augmented phosphorylation of the JNK kinase (136).  
All these aspects demonstrate that our model can be used to investigate the 
mechanisms involved in obesity and analyze the anti-inflammatory and anti-oxidant 
effects of bioactive food like Anthocyanins. 
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Abstract 
 
Epidemiological and preclinical studies have demonstrated that bioactive foods like 
flavonoids, polyphenolic compounds derived from fruits and vegetables, exert a 
protective action against obesity, cardiovascular disorders and Adipocyte Tissue 
Macrophage infiltration (ATM). All these pathologies are characterized by increase 
in reactive oxygen species (ROS) and in pro-inflammatory cytokines that have been 
shown to favor the migration of immune cells, particularly of macrophages, in 
metabolically active organs like the liver and adipose tissue, that in Drosophila are 
constituted by a unique organ: the fat body. This study, using a unique Drosophila 
model that mimics human ATM, reveals the beneficial effects of flavonoids to 
reduce tissue-inflammation. Our data show that anthocyanin-rich food reduces the 
number of hemocytes, Drosophila macrophages, infiltrating the fat cells, a process 
that is associated with reduced production of ROS and reduced activation of the 
JNK/SAPK p46 stress kinase, suggesting a fundamental function for anthocyanins 
as antioxidants in chronic-inflammation and in metabolic diseases. 
 
Introduction 
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Obesity is a metabolic syndrome occurring worldwide, and often associated with 
other chronic diseases such as cardiovascular disorders, type II diabetes and cancer 
[1]. 
The onset of obesity is the result of multifactorial elements, including a sedentary 
lifestyle, genetic predisposition, ethnicity and environmental factors (such as organic 
pollutants) [2], these factors with a diet rich in fats and sugars and poor in 
phytonutrients may result in weight gain and subsequently lead to metabolic 
disorders [3,4].  Obesity is known to trigger a low-grade of inflammation in 
metabolically active tissues and in organs such as the liver and adipose tissue [5-8]. 
Inflammation is the result of cellular and humoral responses with the scope to protect 
the organism from various insults, including infection and tissue damage, in attempt 
to rescue tissue homeostasis [9,10]. 
 
In humans, the adipose tissue regulates lipid homeostasis, and in normal conditions 
controls the storage of energy reserves in the form of triglycerides as well as 
functioning as an endocrine organ, producing a variety of pro-inflammatory 
cytokines such as IL-1, 6, and 8, IFNγ, TNFα [11,12]. In pathological conditions, 
such obesity or metabolic syndrome, the adipocytes start to alter the production of 
these pro-inflammatory cytokines, which results in the activation of the innate 
immune system with recruitment of immune cells including macrophages leading to 
a state of chronic inflammation or ATM [7]. In addition, lipid accumulation and 
chronic inflammation in obese people are associated with a permanent increase of 
oxidative stress and with the production of high levels of reactive oxygen species 
(ROS) [13,14], which is often associated with the activation of the c-Jun-NH2-
terminal kinase (JNK/SAPK) p46, member of a mitogen-activated protein kinases 
(MAPKs) downstream of JNK signaling [15]. This pathway is highly conserved in 
Drosophila, and consists a cascade of phosphorylation events starting with the 
activation of the JNKKK kinases, consisting of the Ask1 and Tak1, that activate 
MKK7, the orthologue of Hemipterous (Hep), and terminates with the activation of 
JNK/SAPK p46 kinase, called basket (bsk) in Drosophila, that is a negatively 
regulated by Puckered (puc), a phosphatase, which itself is a target of JNK/SAPK 
p46 kinase (see Figure 3E) [16]. 
This pathological situation influences other organs by altering their functions. 
Furthermore the adipose tissue from obese individuals exhibits a reduced capacity 
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to store fat leading to an increase of circulating free fatty acids (FFAs) that promotes 
insulin resistance and damages the mitochondrial membrane thereby enhancing the 
production of ROS causing oxidative stress [17-19].  
Epidemiological evidence suggests that a high intake of bioactive food is associated 
with a lower risk of developing chronic diseases like obesity [20]. Bioactive foods 
may influence the physiological and cellular activities of oxidative pathways and in 
recent years the attention has been focused on a class of secondary metabolites 
present in plant foods called flavonoids that seem to possess beneficial properties in 
preventing chronic diseases [21,22]. The possible health benefits of flavonoids are 
linked to their potent antioxidant and free radical scavenging activities demonstrated 
in vitro and in vivo using different animal models [23]. Among the different classes 
of flavonoids, anthocyanins represent the major red, purple and violet pigment in 
many plants and fruits. In vivo studies showed that anthocyanins added to the diet 
stimulate the secretion of insulin and decrease the generation of ROS [21,24]. 
Preclinical studies performed on human demonstrate that dietary-anthocyanins have 
a positive biological effect against obesity-induced inflammation and oxidative 
stress [24,25], which is associated with a lower risk of type 2 diabetes. This 
potentially important application creates a high interest in understanding the action 
of these natural bio-products in preventing metabolic diseases. 
 
In order to study the mechanisms that control the anti-inflammatory response to 
flavonoids, we took advantage of a previously unrecognized conserved functional 
relationship between the immune cells, called hemocytes (macrophage like cells) 
and adipocytes (larval fat body, FB) [26]. Drosophila FB- a metabolic tissue with 
similar physiological functions to the mammalian adipose tissue and liver- acts as a 
functional unit to control key metabolic processes and the native immune response, 
in addition to storing fats and sugars [27]. In Drosophila the immune response is 
orchestrated by the hemocytes, that are circulating cells in the hemolymph, present 
at all stages of the life cycle and compose the fly’s innate immune system [9,28-33]. 
Hemocytes are essential mediators in the cell-cell communication process: they have 
been shown to mediate a response between the fat body and tumor cells to control 
their growth [34] and to promote proliferation of epithelial cells in response to the 
release of ROS following cell death in cells of the imaginal discs [35].  
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Using our model of obesity, we observed that hemocytes infiltrate the FB of obese 
larvae mimicking the chronic inflammation present in human obesity (manuscript in 
submission). In this study we report that treatment with anthocyanin-enriched food 
results in a significant decrease in the number of hemocytes infiltrating the FB 
concomitantly to a reduction in ROS and of the phosphorylation of JNK/SAPK stress 
kinase. 
 
Our data demonstrate that the mechanisms driving the protective role of bio-products 
like anthocyanins in vivo as anti-inflammatory and anti-oxidants are conserved in 
Drosophila. In addition, they highlight the potential use of our model to study the 
complex relationship between inflammation and obesity and corroborate the positive 
action of anthocyanins to combat chronic inflammation in humans. 
 
Materials and methods  
 
Fly stocks and husbandry. The Hml-RFP/CyO is a gift from Katja Brückner at 
UCSF.The P0206-Gal4 from [36], UAS-CG7839RNAi (BL 25992 ) is an RNA 
interference lines to reduce the expression of the  CG7839 gene, encoding for the 
orthologue of a ribosomal protein Noc1, herein the CG7839RNAi will be called Ni. 
Fly cultures and crosses were grown on standard fly food composed of yellow corn, 
sugar, yeast molasses-base at 25°C. 
  
Feeding experiment and chemical compounds. Crosses were kept in culture bottles 
perforated to provide adequate air circulation and eggs were collected on a grape 
agar plate (5%) supplemented with dry yeast every 3 hours. First instar larvae were 
collected after 24 hours AEL (after Egg Laying) and shifted into vials containing 
different food. First instar larvae were reared with 2 g of standard food, hereafter 
Normal Food (NF) and 5 ml of each flavonoid (FL) extract, one containing only 
flavonoids (NF + FL) and another extract containing flavonoids and 0.24 mg/ml 
anthocyanins (NF + FL + ACN). All these phenolic compounds were extracted from 
the cobs of yellow and purple corn (gift from Katia Petroni and Chiara Tonelli, 
University of Milan), only the purple extract is rich in anthocyanins, while the 
content of other flavonoids is the same in both extracts (the content of flavonoids 
present in the extracts are reported in [37]). 
 
Hemocytes quantification and size analysis in larval fat bodies. To label in vivo 
plasmatocytes, which comprise more than 95% of the hemocytes population in the 
Drosophila larva, we used the transgene HmlΔ-DsRed (Hml-RFP) that contains the 
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promoter for hemolectin, expressed in the hemocytes, fused with the Red 
Fluorescence Protein (RFP) [38]. Fat bodies from 20 larvae at 5 and 12 days AEL 
were dissected in phosphate-buffered saline (PBS) pH 7.4 and fixed in 4% 
paraformaldehyde (PFA) for 30 minutes. Hoechst 33258 (Sigma Aldrich) was added 
to stain DNA in a final concentration of 1 μg/ml. After washing with PBS, fat bodies 
were mounted onto slides with DABCO-Mowiol and images were acquired using an 
SP2-LEICA Lasertechnik GmbH confocal microscope. Images were analyzed with 
the ImageJ software. In the order to analyze the cell size, the larval fat bodies were 
fixed in 4% PFA, permeabilized with 0.2% Triton X-100 in PBS, rinsed in PBS 1X 
and membranes were stained with 1:100 Alexa Fluor 488 Phalloidin to visualize the 
cytoskeleton through the binding between Phalloidin and F-actin, and Hoechst 
33258 for nuclei, then mounted onto slides with DABCO-Mowiol. Photographs 
were taken using confocal microscopy and the area of adipose cells for each fat body 
was calculated with ImageJ software. In order to visualize lipids, fat bodies were 
stained with Nile-Red (Sigma Aldrich) and with Alexa Fluor 488 Phalloidin 
following the protocol in [39]. 
 
In vivo detection of ROS using Dihydroethidium (DHE). DHE is used to detect 
cytosolic superoxides and radical oxygen species (ROS). The reaction between DHE 
and superoxide anions generates a highly specific red fluorescent product 
(ethidium), which intercalates with DNA. ROS levels were detected in live tissue as 
described in [40]. Briefly, larval fat bodies at 5 and 12 days AEL were dissected in 
Schneider’s insect medium (GIBCO). After incubation in 30 μM DHE (Invitrogen) 
for 5-7 minutes in the dark at room temperature, fat bodies were washed three times 
with Schneider's medium and immediately mounted with VECTASHIELD Antifade 
Mounting Medium.  
 
RNA extraction and quantitative RT-PCR. Total RNA was extracted from 8 whole 
larvae using QIAGEN RNeasy Mini Kit. 1 μg total RNA from each genotype was 
reverse-transcribed into cDNA using SuperScript IV MILO Master Mix 
(Invitrogen). The obtained CDNA was used as the template for quantitative real-
time PCR (qRT-PCR) using SYBR Premix Ex Taq-Tli RnaseH Plus II (TaKara), 
analyzed on a RT-PCR BIORAD thermocycler machine. In these experiments, gene 
expression levels were normalized to actin mRNA, used as the internal control. The 
following primers for qRT-PCR were used: actin5c  5’- 
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CAGATCATGTTCGAGACCTTCAAC-3’ (R) and 5’-
ACGACCGGAGGCGTACAG-3’ (F) and E74B  5’-
GAATCCGTAGCCTCCGACTGT (R) and 5’- 
AGGAGGGAGAGTGGTGGTGTT (F) [39]. 
 
Protein extractions, and immunoblotting. The larval fat bodies (10 for each 
genotype) were dissected in Schneider’s medium serum-free and lysed in 80 μl of 
lysis buffer 1X (50 mM Hepes pH 7.4, 250 mM NaCl, 1 mM EDTA, 1.5% Triton 
X-100). Protease inhibitor cocktail (Sigma-Aldrich) was added to inhibit protease 
and phosphatase activities. Samples were sonicated two times for 10 seconds, and 
then centrifuged. Protein concentration was determined by Bradford protein assay 
(Bio-Rad). The samples were boiled in 1X SDS, then separated on 10% SDS-
polyacrylamide gels and blotted. Membrane was incubated with primary antibody 
anti-phospho-p46 SAPK/JNK (Cell Signaling #9521) or anti actin (Hybridoma 
Bank) overnight at 4°C in blocking buffer then washed in 0.1% Tween 20 with 
TRIS-buffered saline (TBST). Appropriate secondary antibody, was incubated for 2 
hours, followed by washing. The signal was revealed with ChemiDoc Touch 
Imaging System (Bio-Rad Lab). 
 
Immunostaining.  Dissected fat bodies from 20 larvae were fixed in a solution of 
4% PFA/PBS for 40 minutes. After permeabilization with 0.3% Triton/PBS, tissues 
were washed in a solution of Tween 0.04%/PBS, saturated with 1% BSA/PBS and 
incubated over-night with anti-SPARC antibodies (1:400), a generous gift from M. 
Ringuette [41] and visualized using anti-Rabbit Alexa555 (Invitrogen).  
 
Statistical analysis. The experiments were repeated at least three times and the 
statistical analysis among the various genotypes was examined by Student's t-test. 
Differences were considered significant if p value were less than 0.05 (*), 0.01 (**), 
0.001 (***) and 0.0001 (****). 
 
Results 
 
Obese larvae have increased size of fat cells and increased hemocytes in the fat 
body.  
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In order to study the ability of hemocytes to infiltrate the fat cells, we blocked 
pupariation (Figure 1A) creating larvae P0206-Gal4;UAS-Ni where the reduction of 
the size of the prothoracic gland, the endocrine organ that produces ecdysone, 
resulted in reduced levels of ecdysone (Figure 1B), leading to animals that develop 
at almost normal rate and continue to feed until 3 weeks with an increased body 
weight (see method). Drosophila FB-cells function as storage for nutrients, which 
synthesize and release energy, and accumulates fat and sugars; in our obese animals 
we observed that the at 12 days AEL the size of the cells from the FBs from P0206-
Gal4; UAS-Ni larvae increased (Figure 1C) due also to the accumulation of fats in 
lipid droplets visible by Nile Red staining (Figure 1D). Those P0206-Gal4;UAS-Ni 
animals acquired phenotypic characteristics of obese individuals, including 
increased triglycerides (TAGs), glucose circulating in the hemolymph, resistance of 
fat cells to stimulation with insulin and increased hemocytes in the FB (manuscript 
in submission).  
 
Chronic inflammation in the adipose tissue is characterized by the infiltration of 
macrophages in the fat cells, we therefore analyzed if a similar event was present in 
the FB of our obese animals. We labeled the hemocytes in vivo using the Hml-RFP 
reporter line that specifically expresses Red-Fluorescence protein in hemocytes and 
introduced this transgene to our genetic background. Hml-RFP positive cells were 
monitored over time to visualize and quantify the number of hemocytes infiltrating 
the FB, from control and obese animals at 5 days AEL and at 12 days AEL in the 
obese larvae. These results showed that FBs from P0206-Gal4/Hml-RFP;UAS-Ni 
animals contain at 5 days AEL a small but significant higher number of hemocytes 
in their FBs (5.2%, p<0.05) as compared to control P0206-Gal4/Hml-RFP (Figure 
1E), furthermore at 12 days the percentage of hemocytes in P0206-Gal4/Hml-
RFP;UAS-Ni animals was drastically increased to (17%, p<0.00001). Hemocytes 
are characterized by the expression of high levels of the cell adhesion protein 
SPARC (secreted protein acidic and rich in cysteine, also known as osteonectin or 
BM 40) [41], morphological analysis of FBs from 12 days P0206-Gal4;UAS-Ni 
animals, showed the presence of crown-like structures of hemocytes, positive with 
anti-SPARC antibodies, that surrounded the fat cells, mimicking similar structures 
described in the fat of obese individuals suffering from chronic inflammation (Fig. 
1F). 
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Figure 1:  Obese larvae have increased hemocytes infiltrating the fat cells 
(A) Ecdysone regulation of larval molting and metamorphosis. Reducing the size of the ring gland 
reduces ecdysone level in P0206-Gal4; UAS-Ni animals. (B) Quantitative RT-PCR in whole larvae 
of the indicated genotype showing the relative expression of E74b mRNA. Actin5c was used as 
control. (C) Relative size of cells from the FBs from animals of the indicated genotypes, at 5 and 
12 days AEL. (D) Nile Red staining for lipids, Phalloidin for membranes, and Hoechst for nuclei, 
of FBs. (E) % of hemocytes infiltrating the FBs of animals at 5 or 12 days AEL, of the indicated 
genotype. Data are expressed as percentage of hemocytes in the cells of FBs. (F) Draw and 
confocal photographs of cell from the FB, showing hemocytes stained with anti-SPARC antibodies 
(RED), while nuclei are visualized using Hoechst (BLUE). Error bars represent SEM (standard 
error of the mean) of three independent experiments. * P < 0,05, *** P < 0,001, **** P < 0,0001. 
 
Obese larvae have increased phosphorylation of JNK/SAPK and of ROS production 
in the FB. 
 
Chronic inflammation in obese people is often associated with high levels of reactive 
oxygen species (ROS) and with the activation of the c-Jun-NH2-terminal kinase 
(JNK/SAPK) p46 [15].  
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We therefore analyzed if in our Drosophila model of chronic inflammation, if there 
was an activation of JNK signaling by looking at the levels of phosphorylation of 
JNK/SAPK p46. Western blot analysis using extracts from FBs of larvae from 
P0206-Gal4 at 5 days AEL or P0206-Gal4;UAS-Ni at 5 and 12 days AEL shows an 
increase in the phosphorylation of JNK/SAPK p46 kinase (Figure 2A). 
 
 
 
Figure 2: Obese larvae show activation of JNK/SAPK signaling and increased ROS 
production. (A) Western blot from lysates of FBs showing the level of phosphorylation of 
JNK/SAPN p46 kinase, in P0206-Gal4 (control) and P0206-Gal4;UAS-Ni animals. Actin was 
used as control loading. (B) Confocal photographs (20x) of cells from FBs stained with DHE (red) 
for ROS, and Hoechst (BLUE) for nuclei. 
 
Since ROS are known to induce the activation of the JNK pathway we then analyzed 
if in the FBs from the obese larvae there was an increase in ROS signaling, using 
DHE as a marker. These experiments show that at 5 days AEL, DHE staining 
increased in FBs from P0206-Gal4;UAS-Ni (Figure 2B, middle panel) animals as 
compared to control (Figure 2B, left panel), moreover DHE staining further 
increased at 12 days AEL (Figure 2B, right panel) suggesting that FBs form these 
animals exhibit significant increase in ROS production over time. 
 
Dietary anthocyanins reduce hemocytes infiltration in FBs and phosphorylation of 
JNKSAPK p46. 
 
Flavonoids (FL) and anthocyanins (ACN) are known to have antioxidant effects 
against inflammation-induced oxidative stress. Therefore, we analyzed if the 
presence of FL or ACN in the diet of the obese animals, had an effect on the chronic 
inflammation and stress phenotypes.  
Staged first instar larvae were transferred to normal standard food (NF) or to food 
enriched with FL only or enriched with FL + ACN, herein called ACN (Figure 3A 
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and material and methods) and their effect on the migration of hemocytes in the FBs 
was quantified by visualizing the number of HML-RFP positive cells on dissected 
FBs using a fluorescent microscope. These experiments show that after 5 days of 
feeding with the different diets, only food containing ACN significantly reduces 
from 5.7% to 3.2% the presence of hemocytes in the FBs of P0206-Gal4;UAS-Ni 
animals, while treatment with FL did not have any effect (Figure 3B). At 12 days 
instead both, FL or ACN diets were able to significantly decrease the number of 
hemocytes (Figure 3B). In addition macroscopic analysis of the shape and number 
of hemocytes showed that at 12 days AEL both FL and ACN treatments were able 
to reduce the formation of crown-like structures of hemocytes surrounding the fat 
cells in P0206-Gal4; UAS-Ni animals (middle and left panel) Figure 3C. We then 
analyzed the effect of FL and ACN diets on the phosphorylation of the stress-
response JNK/SAPK p46. FBs from animals growing in the different diets were 
dissected at 5 and 12 days AEL and phosphorylation of JNK/SAPK was analyzed 
by western blot. These experiments showed that at 5 days AEL, feeding with ACN 
significantly reduced the phosphorylation of JNK/SAPK p46 in FBs from P0206-
Gal4;UAS-Ni (Figure 3D), while after 12 days AEL both diets with FL and ACN 
were able to significantly reduce JNK/SAPK p46 phosphorylation, suggesting a 
potential role at later points for FL in reducing oxidative stress. 
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Figure 3: Anthocyanins-rich diet reduces the infiltration of hemocytes in the FBs and the 
phosphorylation of JNK/SAPK. (A) Scheme of the different diets NF: Normal Food, or enriched 
in FL: flavonoids, or ACN: anthocyanins. (B) % of hemocytes in the cells of the FBs from animals 
at of the indicated genotypes and fed with the indicated diets at 5 or 12 days AEL. (C) 
Confocal images showing hemocytes expressing Hml-RFP (RED) and nuclei stained with Hoechst 
(BLUE) from animals at 12 days AEL, upon feeding with NF, FL or ACN enriched diets. (D) 
Western blot from lysates of FBs showing the level of phosphorylation of JNK/SAPN p46 kinase, 
in P0206-Gal4 (control) and P0206-Gal4; UAS-Ni animals fed in FL or ACN enriched diets. FBs 
were taken at 5 or 12 days AEL. Actin was used as control loading. (E) Model of JNK signaling 
and potential action of anthocianins. Error bars represent SEM (standard error of the mean) of 
three independent experiments. * P < 0,05, ** P < 0,01, ***  P < 0,001, ****  P < 0,0001   
 
4. Discussion 
 
Obesity and metabolic disorders are pathological conditions associated to our diet 
enriched of fats and sugars or to a sedentary life, but also to environmental factors 
that may pollute our food with chemicals that affect lipid metabolism. As 
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consequences we are seen an increase in cardiovascular diseases, type 2 diabetes and 
a chronic inflammation of the adipose tissue (ATM) induced by the persistent 
infiltration of macrophages into the fat cells, for which the mechanisms are not 
totally understood but have been associated with an oxidative stress condition 
present between the immune cells in the metabolic tissues. In order to study in vivo 
these relationship, we have taken advantage of the conserved relationship in 
Drosophila between the immune cells (hemocytes) and the fat body (adipose tissue) 
to study how bio-products like flavonoids in particular anthocyanins, that are known 
to act as antioxidants and that are naturally present in our food, may ameliorate or 
counteract the migration of the hemocytes into the FB using our animal model that 
mimics chronic inflammation in vertebrate (ATM). 
 
Anthocyanins are a class of flavonoids classified as bioactive food have been shown 
to ameliorate hyperglycemia, insulin sensitivity and fat accumulation in obese mice 
fed to an high fat diet, while in vertebrates studies identify a beneficial effect by 
anthocyanins in combating inflammation-related diseases such as diabetes, 
cardiovascular diseases and obesity [25,42,43]. Moreover, clinical studies in humans 
demonstrate that higher consumption of anthocyanins is associated with weight loss 
in both men and women, and reduces the risk of developing chronic diseases with a 
mechanism poorly understood [24,44]. 
 
In this study, we are using our innovative model that mimic obesity in flies, where 
upon blocking growth by reducing ecdysone, the animals develop at almost normal 
rate but continue to feed with an increase in body weight and in the fat cell-size, 
these animals acquire the characteristics of obese people, with an accumulation of 
TAGs and insulin resistance (manuscript in preparation). Moreover, these animals 
present an infiltration of hemocytes (macrophage-like cells) within the cells of the 
FB that progressively increases until the formation of the typical “crown-like 
structures” described in obese patients suffering from ATM [5]. We demonstrate that 
in FBs from these obese animals there is increased production of ROS, indicating 
the presence of an oxidative stress that may be responsible to the augmented 
phosphorylation of the JNK/SAPK p46 stress kinase. Because the molecular 
mechanisms that regulate lipid metabolism are highly conserved between humans 
and flies [45,46] and hemocytes have been shown to be functionally equivalent to 
macrophages we can speculate that the mechanisms underline these humoral 
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responses are conserved also in flies. Therefore, we use our obesity model to 
investigate the antioxidant effect of flavonoids and anthocyanins to chronic 
inflammation. In our study, we find that a diet rich in anthocyanins reduces 
hemocytes migration in the larval FB and decreases the accumulation of TAGs in 
the fat cells (not shown) ameliorating several characteristics of the obese 
phenotypes. Moreover, we showed that anthocyanins reduce the production of ROS 
in cells of the FB, and significantly attenuate the phosphorylation of JNK/SAPK p46 
kinase providing evidence that may play a key role in regulating the JNK-mediated 
cellular stress responses and to control ROS signaling. 
 
The interplay of signals that regulate the non-autonomous responses between 
hemocytes and the cells of the FB is coming up as a new field for important studies, 
indeed recently hemocytes have been shown to be responsible of mediating an 
humoral immune response in a model for tumor growth, were they were shown to 
trigger signals responsible of killing the tumor cells through a non autonomous 
mechanism mediated by the activation of cytokines of the Toll and Eiger/TNFα by 
the fat body [34]. More recently, hemocytes were shown that upon stress conditions 
they are able to migrate near epithelial cells and to produce ROS to induced the 
release of Eiger/TNFα by the epithelial cells through the activation of the JNK 
signaling pathway, suggesting also in this case the presence of non-autonomous 
signals between the hemocytes and the cell of the epithelium necessary for tissue 
homeostasis [47] [35,48]. In a similar way, we can speculate that the hemocytes in 
the FB from obese animals maybe be activated by the oxidative stress signals (ROS), 
present in the FB, that trigger signals to induce the production of cytokines of the 
Toll and Eiger/TNFα that further aggravate the oxidative stress condition that attract 
the hemocytes that constitutively migrate into the fat cells causing a status of chronic 
inflammation. 
In our experiments, we show that anthocyanins are able to reduce the activation of 
JNK/SAPK p46 stress kinase. As mention before, JNK pathway is activated 
upstream by ROS and by cytokines including Eiger/TNFα, this pathway is inhibited 
by a negative regulatory feed beck that induces the transcription of the phosphatase 
puckered (Figure 3E). In our model, we can speculate that anthocyanins may either 
directly block cytokines upstream of JNK signal, for example by controlling 
Eiger/TNFα signaling or they may contribute to the activation of the negative 
feedback that involved the activity of puckered. 
40 
 
Interestingly, anthocyanins were shown to act concomitantly with detoxification 
enzymes such as superoxide dismutase, catalase, glutathione peroxidase, 
glutathione-S-transferase (GST) and glutathione reductase to reduce oxidation. In 
Drosophila Gst-D1 [49] and jafrac, an inhibitor of cell death, together with 
puckered, were shown to be transcriptional targets of jun-fos activity in response to 
the activation of JNK pathway, and these genes were shown to negatively counteract 
the oxidative stress response [50]. Our preliminary data however did not find any 
regulation in the expression of GstD1 in the fat cells from the obese animals upon 
feeding with FL or ACN anthocyanins (data not shown) suggesting that probably 
this enzyme is not involved in the regulation of JNK signaling by anthocyanins in 
these cells. 
 
In conclusion, with the present study we provide for the first time a strong evidence 
of the potential use of anthocyanins in the diet to control chronic- inflammation and 
provide a link to the oxidative stress that characterize the adipose tissue in obese 
animals. We were able to evidence the ability of anthocyanins to decrease in vivo 
the phosphorylation of JNK/SAPK p46 stress kinase, thus providing a new insight 
into the mechanism of phenolic compounds in the treatment of inflammation in 
adipose tissues, a field of currently study since the lack of a better knowledge of the 
mechanisms that regulate or control ATM in pathologies such as obesity and 
metabolic disorders. 
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Abstract 
 
Cancer is a multistep disease driven by the activation of specific oncogenic pathways 
concomitantly with the loss of function of tumor suppressor genes that act as 
sentinels to control physiological growth. The conservation of most of these 
signaling pathways in Drosophila, and the ability to easily manipulate them 
genetically, has made the fruit fly a useful model organism to study cancer biology. 
In this review we outline the basic mechanisms and signaling pathways conserved 
between humans and flies responsible of inducing uncontrolled growth and cancer 
development. Second, we describe classic and novel Drosophila models used to 
study different cancers, with the objective to discuss their strengths and limitations 
on their use to identify signals driving growth cell autonomously and within organs, 
drug discovery and for therapeutic approaches. 
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Introduction 
 
The fruit fly, Drosophila melanogaster, is used as a model organism to study 
disciplines ranging from fundamental genetics to the development of tissues and 
organs. Drosophila genome is 60% homologous to that of humans, less redundant, 
and about 75% of the genes responsible for human diseases have homologs in flies 
(Ugur et al., 2016). These features, together with a brief generation time, low 
maintenance costs, and the availability of powerful genetic tools, allow the fruit fly 
to be eligible to study complex pathways relevant in biomedical research, including 
cancer. Indeed, publications that use flies to model cancer have exponentially 
increased in the last 10 years, as shown in the graph of Figure 1, suggesting the 
relevance of this model to cancer research. 
 
Figure 1: Graph representing the number of publications in PubMed found with the terms 
“Drosophila cancer model”, in the last 48 years. 
 
In this review we first describe the basic biological mechanisms responsible for 
uncontrolled growth conserved between humans and flies. We placed a particular 
emphasis on the characterization of epithelial tumors from most studied models (gut 
and brain), to novel approaches for studying tumor-induced angiogenesis, prostate, 
thyroid and lung cancers, with the goal to discuss their strengths and limitations. In 
the second part, we analyze few physiological mechanisms that uncover potential 
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non-autonomous mechanisms controlling growth, including the relation between the 
immune cells (macrophages) and the growth of epithelial cells, or the function of 
lipid metabolism in cancer growth. Finally, we discuss how Drosophila models are 
used to find novel interesting therapeutic approaches. 
 
1.0 Properties of epithelial cancer cells 
Cancer cells are characterized by unrestrained proliferation that results from defects 
in signaling driving cellular growth, apoptosis and changes in metabolic pathways. 
At cellular level, the hyperproliferative status of cancer cells is mainly due to the 
activation of growth signals induced by proto-oncogenes (e.g. the RAS/RAF/MAPK 
axis), which function downstream of receptor signaling cascades, and are 
deregulated in 25% of human tumors (Samatar and Poulikakos, 2014). Tumor cells 
escape the anti-proliferative effect of tumor suppressor genes, such as RB 
(retinoblastoma-associated) and TP53 genes (Duronio and Xiong, 2013), through 
mutations in these genes, which result in uncontrolled growth (Hanahan and 
Weinberg, 2000, 2011; Hariharan and Bilder, 2006). Apoptotic cell death represents 
another physiological mechanism to maintain cellular homeostasis, and cancer cells 
have developed strategies to evade apoptosis, i.e. by increasing the activity of anti-
apoptotic genes (Bcl-2, Bcl-xL, Bcl-w) and of pro-survival factors (Igf-1, Igf-2) or by 
downregulating the action of pro-apoptotic genes (Bax, PUMA, Bin) (Hanahan and 
Weinberg, 2011). Another characteristic of cancer cells is the reactivation of 
telomerase, present in 90% of human cancers, that allows them to replicate 
unlimitedly (Kumar et al., 2016).  
Cancer cells also exhibit alterations in metabolic pathways that contribute to their 
survival. Rapidly proliferating cells have a high metabolic rate and suffer from low 
oxygen conditions (hypoxia). In epithelial tumors, this condition triggers the so-
called angiogenic “switch” where the quiescent vascular network is induced to 
proliferate by the secretion of pro-angiogenic factors, such as VEGF (Vascular 
Endothelial Growth Factor) and FGF (Fibroblast Growth Factor) (Hida et al., 2018), 
allowing for the formation of new vessels that penetrate into the tumor mass to 
supply oxygen and nutrients (Carmeliet and Jain, 2011). Cancers cells also exhibit a 
metabolic switch where they reprogram their metabolism to use an alternative and 
less abundant anabolic pathway to sustain their growth. In particular they switch 
from oxidative phosphorylation to anaerobic glycolysis, where glucose is used to 
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produce lactate, through a process called the “Warburg effect” (Pavlova and 
Thompson, 2016; Vander Heiden and DeBerardinis, 2017). This metabolic switch is 
not yet completely characterized but is supported by the activation of oncogenes, 
including Myc that also activates glutaminolysis to fuel the TCA cycle with 
anaplerotic reactions to produce the intermediates necessary for cellular biosynthesis 
(Hsieh and Dang, 2016).  
The last stage of tumorigenesis is represented by the invasive and metastatic 
capabilities of tumor cells to disrupt the apical-basal cell polarity, a process that is 
associated with the downregulation of cell-cell contact molecules and the release of 
metalloproteases (MMP1), lytic enzymes that degrade the extracellular matrix 
(ECM) allowing tumor cells to escape and colonize an environment that suites them 
and to acquire new oncogenic properties (Lambert et al., 2017; Massague and 
Obenauf, 2016). A variety of studies are now focused on how the tumor micro 
environment (TME), a specific niche composed of fibroblasts, lymphocytes and 
immune cells, that may shape pre-cancer cells for their progression into cancer cells 
and it may select the development of metastasis (Massague and Obenauf, 2016). 
Emergent evidence suggests also a key role for non-autonomous signals released by 
the cells composing the niche, particularly from cancer-associated fibroblasts 
(CAFs), that are essential to support the growth of cancer cells in this  “new” 
metabolic environment (Lambert et al., 2017). 
2.0 Cancer modeling in Drosophila  
Most of the signaling pathways controlling cell growth and invasion in mammals 
have a conserved function in flies; allowing their modulation into several models 
that mimic a tumor’s biology in a simple model organism like Drosophila (Millburn 
et al., 2016). The combination of genetic screens with the availability of powerful 
recombination techniques enabled also a rapid characterization of the primary 
function of conserved oncogenes and of tumor suppressor genes in a whole animal 
(Sonoshita and Cagan, 2017). In addition, recent studies using Drosophila imaginal 
discs explored the mechanisms that govern growth in epithelial tumors and their 
interaction with the local TME and stromal cells, including some steps in the 
recruitment of the immune cells (macrophages) to the tumor mass (Herranz et al., 
2016).  
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3.0 Epithelial tumors in Drosophila   
About 90% of human cancers are of epithelial origin (Hanahan and Weinberg, 2000). 
Epithelial tissues are characterized by a specific cell architecture composed of 
junctions and apical and baso-lateral membrane domains that are crucial for the 
maintenance of cell-physiological functions. Loss of cell adhesion and cell polarity, 
with an increase of cell motility, are indeed characteristic early cancer traits. In this 
context, Drosophila larval imaginal discs, are a monolayer epithelium that is limited 
apically by a squamous epithelium (peripodial membrane) and, basally to the notum, 
by a layer of myoblasts embedded in Extracellular Matrix, and constitute a perfect 
system in which to model the onset of epithelial cancer progression. These larval 
organs are indeed morphologically and biochemically comparable to mammalian 
epithelia (Wodarz and Nathke, 2007). Moreover, the prominent signaling pathways 
that regulate growth in humans are conserved in the fruit fly (Figure 2), allowing the 
use of this animal model to examine the hallmarks of cancer (St Johnston, 2002). 
During the last few years, the imaginal wing and eye discs have been used 
successfully to study tumor growth and invasion, to investigate the function of 
cancer genes, and to perform chemical screenings (Tipping and Perrimon, 2014). 
The imaginal discs also represent an excellent model to analyze oncogenic 
cooperation: thanks to the use of the MARCM system (Lee and Luo, 1999), it is 
feasible to induce simultaneously in single cells mutations in tumor suppressor genes 
(e.g. mutations in cell polarity genes and Hippo pathway components and 
interactors) and oncogenic activating mutations, or to overexpress specific genes 
(e.g. EGFR, Ras, Myc, Yorki), resulting in tissue overgrowth, alteration of the 
normal tissue architecture, disruption of the basement membrane, and 
invasive/metastatic behavior (Brumby and Richardson, 2003; Pagliarini and Xu, 
2003a; Wu et al., 2010). 
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Figure 2: Major pathways converging on uncontrolled growth in Drosophila epithelial cells. 
The signaling pathways outlined confer growth, migration and invasive capabilities to epithelial 
cells both in vertebrates and flies. Models that mimic the growth of epithelial cancer cells and their 
ability to undergo metastasis in Drosophila have been established by inducing the cooperation 
between oncogenes (RED) like the active form of Ras (RasV12) together with the loss of function 
of cell polarity genes (GREEN) (Brumby and Richardson, 2003; Pagliarini and Xu, 2003b). 
Alteration of cell polarity with the downregulation of the SWH (Salvador-Hippo-Warts) pathway, 
together with RasV12, triggers downstream events, including activation of the MAPK signaling that 
stabilize Myc protein (Galletti et al., 2009) resulting in robust cellular growth. Activation of the 
JNK signaling, with the concomitant loss of cell polarity, induces metalloproteases (MMP-1) and 
confers to the epithelial cells the distinct characteristics of migration and invasion, hallmarks of 
tumor growth (Igaki et al., 2006; Ma et al., 2017; Uhlirova et al., 2005). 
 
3.1 Marks of alteration in epithelial cells 
 
3.1.1 Loss of cell polarity 
 
Cellular junctions and a proper apical-basal cell polarity are fundamental for the 
maintenance of epithelial tissue architecture and function. During early cancer 
stages, tissues lose these properties and cells subvert their normal growth rate and 
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acquire invasive and migratory behaviors (Bryant and Mostov, 2008; Wodarz and 
Nathke, 2007). In Drosophila, three complexes establish and maintain epithelial 
polarity: the Crumbs/Stardust/PATJ/Bazooka, the Par6/aPKC (atypical protein 
kinase-C) and the Scrib/Dlg/Lgl (Scribble/Discs large/Lethal giant larvae) 
complexes, which are respectively placed at the apical, subapical and baso-lateral 
membrane domains. Alterations in these proteins provoke continued cell 
proliferation, loss of differentiation and complete loss of tissue architecture, 
resulting in neoplastic overgrowth (Bilder, 2004; Grzeschik et al., 2010; Johnson 
and Halder, 2014). lgl was the first neoplastic tumor suppressor gene discovered in 
Drosophila and its loss leads to an abnormal growth of the imaginal structures and 
the larval brain. In addition, lgl mutant tissues, and tissues bearing dlg or scrib 
mutation, have the ability to form secondary tumors in the thorax, brain, wings, 
muscles, intestine and ovaries (Woodhouse et al., 1998). The loss of cell polarity 
impacts cell proliferation through the deregulation of the Hippo (Hpo) pathway, a 
signaling cascade involved in organ size maintenance (Lu et al., 2010). It is not yet 
fully known how lgl activity interacts with the Hpo cascade, but it was observed that 
its downregulation up-regulates cell cycle genes (such as Cyclin E and E2F1) 
(Grzeschik et al., 2007) and permits the nuclear translocation of Yorkie (Yki), the 
downstream effector of the Hippo pathway, causing the activation of its target genes, 
including MYC, that was found to be important for the growth of lgl mutant clones 
in a competitive environment (Froldi et al., 2010). In humans, two lgl homologs have 
been discovered, HUGL-1 and HUGL-2, with HUGL-1 rescuing all the defects of 
the fly lgl mutant (Grifoni et al., 2004). HUGL-1 loss of function has been associated 
with a series of human malignancies (Grifoni et al., 2007; Lu et al., 2009; 
Schimanski et al., 2005). Finally, while the human genome encodes for only one 
homolog of the tumor suppressor scrib, a number of homologs are known for dlg 
which have been implicated in different types of cancer (Halaoui and McCaffrey, 
2015). 
 
3.1.2 Growth Signaling 
 
The Salvador-Warts-Hippo (SWH) tumor suppressor pathway was discovered 
first in Drosophila as a regulator of organ size (Pan, 2010; Yu et al., 2015) and later 
in humans, where it was found to be fundamental in the regulation of cancer growth 
(Harvey et al., 2013). The physiological activation of the Hippo (HPO) kinase, 
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(MST1/2 in human)(Harvey et al., 2003) consists in the phosphorylation of Warts 
(WTS), (LATS1/2 in human) (Genevet et al., 2010; Yu et al., 2010) and in the 
activation of the phosphorylated core complex, that includes Salvador (SAV in 
human)(Tapon et al., 2002) and Mob/MATS, that in turn, phosphorylate Yki 
(YAP/TAZ in humans)(Oh and Irvine, 2008). Phosphorylated Yki is sequestered and 
degraded in the cytoplasm, resulting in the inhibition of its nuclear transcriptional 
activity and oncogenic function (Harvey et al., 2013). Upstream, the Hippo cascade 
is regulated by components of cell junctions, including cell adhesion molecules such 
as Merlin, a homolog of the human Neurofibromatosis Type 2 (NF2) (Genevet et al., 
2010; Yu et al., 2010), which acts as tumor suppressor; the cadherin Fat in complex 
with Dachsous; and by cell polarity regulators such as Crumbs (Harvey et al., 2013; 
Robinson et al., 2010). Alterations in the composition of the core proteins (HPO, 
WTS, SAV, MATS) of the pathway trigger Yki translocation into the nucleus that 
binds tissue-specific partners and induces the expression of its target genes, among 
them: CyclinE, dIAP1 and MYC (Harvey et al., 2003; Neto-Silva et al., 2010; 
Pantalacci et al., 2003; Ziosi et al., 2010). This articulated system is also tightly 
regulated by other signaling pathways: for example, in the Drosophila imaginal wing 
disc, Lgl or aPKC deregulation results in JNK activation to promote Yki nuclear 
translocation via phosphorylation of Ajuba (Jub), an upstream regulator of the 
cascade that binds to and inhibits Wts kinase activity (Sun and Irvine, 2013). In 
addition to the regulation of cell-cell interaction signals, components of the Hippo 
pathway have been found to be sensitive to mechanical stress (Panciera et al., 2017). 
This mechanotransduction function is critical in the control of physiological 
pathways, and its deregulation may contribute to the abnormal cell behavior in 
diseases such as cancer, where the cells in the tumor have to sustain physical forces 
generated by tissue overgrowth. Interestingly, this last function has shown 
differences in the behavior of Yki between human and flies: indeed, in Drosophila 
the Yki protein does not respond to integrin stimulation, while in mammalians 
integrin signaling promotes YAP/TAZ activity. One possible explanation for this 
different behavior may be that the N-terminus of Yki is missing a domain necessary 
to bind PDZ-containing proteins, which is found in its human counterpart YAP, and 
is necessary for the activation of the integrin-Src adhesion branch of the pathway 
(Elbediwy and Thompson, 2018). However, an interesting and potential explanation 
for this difference comes from a comparative analysis of the Yki protein and the 
evolution of the different epithelia: this analysis outlines how in Drosophila the 
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apical membrane of the columnar epithelium is well differentiated in its function to 
activate the Hippo pathway, whereas in mammals the multilayer of cells lacks a 
functional apical domain, and the activation of YAP/TAZ relies on the 
activation/signal from the integrin adhesion pathways of the stem cells on the basal 
layer of the epithelium (Elbediwy and Thompson, 2018). 
 
The RAS/RAF/ERK signaling cascade is one of the most conserved pathways in all 
organisms, including Drosophila. This pathway is part of the MAP kinase signaling 
that, in addition to ERK1/2, also includes JNK1/2/3, p38/MAPK and ERK5, which 
mainly respond to stress activators (Morrison, 2012). Highly conserved in flies, 
ERK1/2 are activated by growth factors such as EGF or FGFs. These ligands bind 
to receptor tyrosine kinases (RTKs) to activate downstream signaling, in particular 
its core complex, which is represented by the guanidine exchange factor Son of 
Sevenless (SOS) that, in turn, activates the small G proteins RAS on the cell 
membrane. This leads to RAF activation and to the formation of the complex with 
the kinase D-Sor also called MAPKK or MEK that, upon phosphorylation of Rolled, 
the fly homolog of MAPK or ERK kinases, induces the activation of its final targets 
(Shilo, 2014). ERK in flies has much fewer targets than those described in 
vertebrates, the most common being the ETS-domain protein Pointed (Pnt). In 
particular PntP2, needs to be phosphorylated for its activation and is the principal 
activator of transcription downstream of many RTKs, and PntP1 is transcriptionally 
induced by MAPK (Shilo, 2014). A second transcriptional repressor is Capicua 
(Cic), an HMG box-containing protein highly conserved in vertebrates (Simon-
Carrasco et al., 2018). Interestingly, in the last couple of years, this protein was found 
to possess oncogenic properties and be overexpressed in many tumors (Simon-
Carrasco et al., 2018). In addition, Cic activity regulates co-target genes upon Yki 
activation, placing this protein at the crossroads of RTKs and SWH pathways 
(Simon-Carrasco et al., 2018). 
Even though MAPK targets in Drosophila are less abundant than in mammals, its 
activation and translocation to the nucleus results in a growth phenotype mimicking 
a few characteristic steps of growth in tumor cells (Brumby et al., 2011). Activation 
of Ras is considered a cancer distinctive trait both in Drosophila and humans, and it 
represents one of the strategies to model human cancer in flies. In Drosophila there 
are three Ras genes but only Ras1 has functional homology with mammalian RAS. 
In the epithelial cells of the wing imaginal disc, Ras1 activation triggers 
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hyperproliferation but also determines cell fate (Prober and Edgar, 2000). Ras 
activation is at the crossroads of other growth factor signaling cascades: recently, a 
link to Hpo function was shown in Drosophila epithelial cells, where Ras activation 
was able to induce the tissues to switch from a pro-differentiative to a pro-growth 
program by modulating SWH’s transcriptional output (Pascual et al., 2017). Ras 
increases cell proliferation also through the transcriptional regulation of growth 
factors and their receptors. For example, it helps promote angiogenesis-like 
mechanisms in tracheal development through secretion of the FGF/EGFR molecules 
(Grifoni et al., 2015; Petit et al., 2002); its activation stabilizes pro-growth signals 
including MYC (Prober and Edgar, 2000), and inhibits pro-apoptotic molecules like 
Hid (Bergmann et al., 1998). Because of all these functional homologies to human 
RAS, its activation in Drosophila is considered a good method to establish models 
that mimic tumor growth. 
 
The JNK Signaling Pathway is activated mainly by oxidative stress, producing 
reactive oxygen species (ROS), and by Eiger, the Drosophila homolog of TNF- . 
Its function is variable and depends also on the cellular environment: it can indeed 
induce cell proliferation and migration, but its major role is to induce apoptosis 
(Igaki, 2009). The signaling core is characterized by Hemipterus/Hep (JNKK) (Glise 
et al., 1995), Basket/Bsk (JNK) (Stronach, 2005) and the AP-1 complex, that 
functions as negative feedback by up-regulating the expression of the Puckered 
phosphatase (Martin-Blanco et al., 1998). The AP-1 complex is composed of Fra 
(Fos-Related Antigen) and dJun (Drosophila Jun) and is the final effector of the 
cascade (Kockel et al., 2001). Upstream Hep is phosphorylated by many JNKK 
kinases (Tak1-12, Mekk1, Ask1, Slpr) and can also be activated by different indirect 
stimuli (e.g. RAS, JNKKKK/Msn, and Eiger). Cell death is induced by the 
expression of the pro-apoptotic genes hid, reaper and grim, whose activity inhibits 
the pro-survival protein dIAP1 (Weston and Davis, 2007). In Drosophila cancer 
cells, the JNK pathway plays a dual role, by suppressing or promoting growth 
depending on the context (Brumby and Richardson, 2003; Cordero et al., 2010; 
Uhlirova et al., 2005). lgl, scrib and dlg mutant cells undergo JNK-mediated 
apoptosis resulting in a mechanism of tumor suppression (Brumby and Richardson, 
2003; Igaki et al., 2006; Uhlirova et al., 2005I). On the contrary, in tumor cells with 
active RAS, apoptosis is blocked and JNK signaling acts as a tumor promoter 
transcribing genes involved in growth and invasion such as MMP1 (Igaki et al., 
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2006; Uhlirova and Bohmann, 2006). The overexpression of activated RAS together 
with Hep (rasv12hepwt) gives cells invasive and metastatic abilities, highlighting how 
these pathways converge to induce transformation in epithelia. 
 
The PI3K/Target of rapamycin (TOR) signaling pathway is a highly conserved 
key regulator of growth.. The binding of insulin-like peptides (ILPs) (fly’s insulin) 
to the receptor (InR) results in the phosphorylation of chico/IRS1-4, and the 
production of phosphatidylinositol-3, 4,5-triphosphate (PIP3) by PI3K, a reaction 
that is counteracted by the lipid phosphatase PTEN (Grewal, 2009). PIP3 recruits 
several Ser/Thr kinases to the plasma membrane, including Akt/PKB and PDK1 (3’-
phosphoinosite-dependent protein kinase-1), while its activation results in the 
inhibition of Glycogen Synthase Kinase-beta (GSK3- ), a conserved kinase that not 
only controls energy metabolism by inactivation of Glycogen Synthase, but also 
regulates Wnt signaling by controlling -catenin/armadillo (Xu et al., 2009) and 
Myc stability (Bellosta and Gallant, 2010). Activation of Akt also inhibits Tuberous 
Sclerosis Complex 1 and 2 (TSC1/2), a tumor suppressor binary complex that 
negatively regulates Rheb, a GTPase upstream of TOR kinase responsible for the 
activation of TORC1. TOR is found in two complexes: TORC1, which includes 
Raptor and LST8 adaptor molecules, is sensitive to amino acids and is inhibited by 
rapamycin; and TORC2, that is composed of LST8 and Rictor adaptor molecules, 
and does not respond to amino acids or rapamycin (Saxton and Sabatini, 2017). 
Activation of TORC1 results in phosphorylation of ribosomal protein kinase p-70-
S6 (S6K) and of eukaryotic translation initiation factor 4E-binding protein 1(4E-
BP1), thereby triggering protein synthesis and initiation of translation. Insulin and 
TOR activities are also balanced by a negative feedback mechanism that is activated 
when S6K is hyper-activated to counteract insulin activity. Under this condition, 
S6K phosphorylates IRS1-4/chico triggering its internalization and subsequent 
proteasomal degradation. This feedback mechanism is reduced in pathological 
conditions, such as the Tuberous Sclerosis Complex syndrome (TSC), where cells 
carrying tsc1 or tsc2 mutations display an abnormal increase in size and exhibit 
constitutive phosphorylation of S6K (Saxton and Sabatini, 2017). As members of 
PI3Ks and TOR signaling are frequently activated in human tumors, they are 
attractive targets for cancer treatment. 
 
3.1.3 Myc and Cell Competition. 
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MYC is one of the most studied oncogenes, and its misexpression is associated with 
various tumor types including meningioma, Burkitt’s lymphoma, medulloblastoma 
and hepatocellular carcinoma (Hsieh and Dang, 2016). Drosophila Myc is the sole 
fly member of the family of transcription factors that in mammals is composed of 
three genes (N-, L-, and c-MYC) (Gallant et al., 1996; Schreiber-Agus et al., 1997). 
Hypomorphic alleles of myc in flies are developmentally delayed and show a 
reduction in cell size resulting in smaller flies (hence the name of the mutant as 
diminutive= small) (Johnston et al., 1999), while null mutants die during larval stage 
(Pierce et al., 2004). Notably, ubiquitous expression of myc increases cell mass 
resulting in enrichment of genes encoding components of the nucleolus and of the 
ribosome; this evidence, concomitantly with Myc’s ability to indirectly stimulate 
RNA pol I and III (Grewal et al., 2005; Hulf et al., 2005; Orian et al., 2005), 
contribute to revealing its role in the control of ribosomal biogenesis, thus mass and 
size. Myc activity is finely regulated, and while its expression is required at 
physiological levels during development, an excess of its activity triggers 
autonomous cell death and unbalanced growth (Grifoni and Bellosta, 2015). 
Therefore, Myc is strictly controlled both transcriptionally and post-translationally, 
where its protein stability is controlled by phosphorylation events downstream of 
RAS/ERK and GSK3  kinases with a signaling conserved in flies and mammals 
(Galletti et al., 2009; Parisi et al., 2011). Myc regulation of the cellular metabolic 
milieu is highly similar in Drosophila to the regulation found in tumor cells 
(DeBerardinis et al., 2008), indeed it was shown that in cells undergoing to a 
metabolic stress (starvation or competitive environment), expression of Myc 
switched their metabolism to increase glycolysis, glutaminolysis (de la Cova et al., 
2014; Hsieh et al., 2015; Parisi et al., 2013), or lipid metabolism to favor survival by 
inducing autophagy (Paiardi et al., 2017; Parisi et al., 2013). Fascinatingly, these 
evolutionary functions of Myc to control mass and metabolism, resulted in the 
selective advantage of growth of epithelial cells described as cell competition and 
characterized in the monolayer epithelia composing Drosophila’s imaginal discs 
Johnston, 2014). Briefly, cells expressing Myc create a competitive environment and 
they grow at the expense of wild-type cells that are killed by non cell-autonomous 
apoptosis (de la Cova et al., 2004; Moreno and Basler, 2004). Myc cells thus behave 
as “winners” and they are able to repopulate the space of the dying “loser” cells that 
are killed by unidentified Myc-dependent mechanisms (Johnston, 2014). Myc-
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induced cell competition was also shown to be necessary in vertebrates to eliminate 
unfit cells (losers) during early embryogenesis (Claveria and Torres, 2016). More 
recently, evidence that sustains a central role for Myc-induced cell competition in 
the early steps of tumor formation have shown Myc present at high levels in cells 
surrounding the tumor near dying cells, potentially allowing the winner cells to 
expand and to eliminate the surrounding wild-type cells, thus establishing the first 
evidence of Myc involved in a tumor growth competitive environment (Di Giacomo 
et al., 2017; Johnston, 2014). Another form of cell competition was shown to be 
regulated by cell polarity genes (lgl, scrib, dlg) and by endocytic genes (such as 
Rab5). Cells mutant for these genes behave as losers and were eliminated by wild-
type cells (Brumby and Richardson, 2003; Menendez et al., 2010); notably the 
expression of oncogenes in those loser clones provided them with super-competitive 
characteristics, i.e. lgl mutant cells over-expressing MYC sent death signals to the 
adjacent wild-type proliferating cells (Froldi et al., 2010), suggesting the presence of 
another mechanism of cell competition driven by different growth forces working in 
combination with cell polarity genes and oncogenic signals.  
 
4.0 Organotypic Drosophila cancer models  
 
4.1  Gut Cancer 
 
Similar to mammalian counterparts, the Drosophila adult gut is specialized in the 
digestion of food, the absorption of nutrients, and for controlling the defense 
response against infection (Tian et al., 2018). Based on these distinct functions, the 
Drosophila gut is composed of three parts: foregut, midgut, and hindgut. Among 
them, the midgut has a distinct architecture that resembles the digestive tract of 
vertebrates. The epithelium is a monolayer that is replenished by Intestinal Stem 
Cells (ISCs) that differentiate to either enteroblasts (EB) or pre-enteroendocrine cells 
(pre-EE), that then differentiate into absorptive enterocytes (EC) or secretory 
enteroendocrine cells (EE).  Thanks to significant similarities in the physiology 
between the Drosophila gut and the intestine of vertebrates (Apidianakis and Rahme, 
2011), Drosophila adult midgut epithelium has been used to study the contribution 
of signaling pathways (i.e. EGFR, Notch, Hedgehog, and Wg/Wnt) to Intestinal 
Stem Cells (ISCs) renewal (Biteau and Jasper, 2011; Jiang and Edgar, 2009; Jiang 
et al., 2011).   
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In vertebrates, the majority of sporadic cases of colorectal cancer and familial 
adenomatous polyposis (FAP) cancer syndrome are associated with activation of 
Wnt signaling (Bienz and Clevers, 2000). In humans, abnormal expression of Wnt 
in ISCs promotes adenoma formation, while deletions in mouse ISCs of the  tumor 
suppressor adenomatous polyposis coli gene APC triggers the initial step of colon-
adenoma formation (Barker et al., 2009), underlying the relevance of both mutations 
in this malignancy. In Drosophila, loss of the Apc gene, leads to the over 
proliferation of ISCs in the gut, resulting in loss of epithelial cell polarity, 
hyperplasia and epithelial overgrowth resembling that of intestinal adenomas 
induced by the loss of APC (Yu et al., 1999). Remarkably, the over-proliferation of 
the Apc -/- cells was rescued by lof mutation of Ras (Wang et al., 2013). On the 
contrary Apc-/- cells expressing an active form of Rasv12 showed a malignant 
transformation including loss of cell polarity and invasive phenotype, highlighting 
the conserved functional cooperation between RAS and APC in controlling proper 
growth in the gut. In Drosophila, intestinal progenitors mutant for the Apc gene 
expand at the expense of the surrounding wild-type cells that die by apoptosis; 
because of this behavior these cells have been defined as “super-competitors” 
(Suijkerbuijk et al., 2016). Apc mutant cells exhibit higher Yki/YAP activity and 
increased JNK signaling, that was also detected at the border between Apc-/- and 
wild-type cell;. moreover, inhibition of apoptosis prevented Apc mutant cells from 
further expansion, suggesting that a competitive behavior in these cells is controlling 
Apc dependent tumor growth (Suijkerbuijk et al., 2016).   
The JNK-Wg signaling is important to control the physiology and regeneration of 
intestinal cells, as ISCs damage leads to an overactivation of the JNK pathway and 
an increase in Wg ligand (Biteau et al., 2008; Cordero et al., 2012b).Wg activity in 
the enterocytes (ECs) indirectly drives the expansion of the ISCs by upregulating the 
JAK-STAT ligands Upd2 and Upd3, acting non-autonomously on ISCs proliferation 
(Tian et al., 2018). Moreover, activation of Wnt drives Myc upregulation in ISCs 
leading to non-autonomous upregulation of Upd3 in the ECs (Cordero et al., 2012a). 
Similarly, loss of Apc1 in the midgut (ISCs) also results in JAK-STAT and EGFR 
pathway hyper-activation, and their removal suppresses the intestinal hyperplasia 
resulting from Apc1 loss, revealing an underlying conserved signaling between flies 
and mammals that controls ISCs proliferation and gut homeostasis (Cordero et al., 
2012a). 
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Another aggressive oncogene that is hyper-activated upon Apc loss, in mouse and 
human intestinal adenomas is the non-receptor tyrosine kinase c-Src (Yeatman, 
2004). This proto-oncogene is amplified or activated in more than 20% of human 
tumors, and its activity has been demonstrated to play a central role in the formation 
of colorectal cancer (CRC). In mice, expression of c-Src increases in the proliferative 
progenitor cells of the “cripta” favoring hyperplastic adenoma formation (Cordero 
et al., 2014). In Drosophila the expression of c-Src orthologs (Src42A and Src62B) 
induces proliferation of the ISCs cells in wild-type animals, and reduction of their 
expression is sufficient to inhibit ISCs’ hyper-proliferation of Apc mutant cells 
(Cordero et al., 2014). Notably, these results recapitulate an important part of the 
function of mammalian c-Src in the progenitor cells of the intestine during 
homeostasis and adenoma formation, suggesting a conserved role of this gene in 
flies in controlling proper ISCs proliferation. 
 
Recently, Drosophila was also used to generate multigenic models of colon cancer 
using data from patients from The Cancer Genome Atlas. Interestingly, the outcomes 
of these models mimicked important properties of human cancers, and can be 
explored and used in chemical screens to find new combinations of cancer-relevant 
drugs (Bangi et al., 2016). Studies, using Drosophila models, to characterize 
intestinal human pathophysiology, revealed the high conservation between these 
species of the mechanisms underlaying colorectal tumorigenesis (Christofi and 
Apidianakis, 2013), and further revealed also the mechanisms that control the 
processes leading to bacterial-mediated inflammation  (Lemaitre and Hoffmann, 
2007). 
  
4.2 Brain cancer 
 
Meningioma are the most common intracranial tumors (Claus et al., 2005; Rogers et 
al., 2015) and frequently linked with mutations in the PI3K catalytic subunit p110α 
isoform encoded by the gene (PI3KCA), or in the v-akt murine thymoma viral 
oncogene homolog 1 (AKT1) gene. Complex interactions were found between 
members of the PI3K/AKT/mTOR pathway and MAPK-, JAK/STAT and Notch-1-
mediated pathways that contribute to meningioma progression (El-Habr et al., 2014). 
Increased risk of meningiomas was associated also with neurofibromatosis type II 
syndrome, where mutations within the tumor suppressor gene Suppressor of fused 
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(SUFU) was associated with hereditary meningiomas (Aavikko et al., 2012) and 
with medulloblastomas (Taylor et al., 2002). In Drosophila SUFU regulates 
Hedgehog (Hh) signaling (Ohlmeyer and Kalderon, 1998), with a similar function 
in humans, where loss of SUFU results in the aberrant activation of the Hedgehog 
(Hh) pathway (Aavikko et al., 2012).  
Of all glioblastomas, the glioblastoma multiforme (GBM) is the most aggressive 
form of gliomas, accounting for approximately 50% of all glial tumors (Phillips et 
al., 2006). In GBM, Notch activity is associated with the control of Glioma Stem 
Cell (GSC), since its activity regulates asymmetric cell division and Notch 
unbalanced expression leads to uncontrolled growth and high malignancy 
(Mukherjee et al., 2016), Notch is an important target for therapeutic intervention in 
brain cancer treatment (Yuan et al., 2015). Several studies in flies demonstrate also 
un important role for Notch signal in controlling growth and stem cell maintenance 
in the brain (Song and Lu, 2011). 
Moreover, the current understanding of asymmetric cell division and its relation to 
tumorigenesis is largely derived from studies on Drosophila neuroblasts (NBs), 
where mutation of a single gene, brain tumor (brat), was shown to alter asymmetric 
stem cell division in larval development, and to generate massive neoplastic growth 
and enlarged adult brain formed entirely of neoplastic NBs (Betschinger et al., 2006; 
Caussinus and Gonzalez, 2005). Suppression of brat expression was used to 
establish a model of glioma stemness in Drosophila, where the upregulation of 
Notch, induced by reducing brat, was the critical node to maintain self-renewal and 
proper stemness (Mukherjee et al., 2016). This observation was also confirmed in 
glioblastomas where the human orthologue of brat, the tripartite motif-containing 
protein-3 (TRIM3), was shown to be necessary to suppress NOTCH1 signaling and 
to control stem cell activity during development to reduce tumor growth (Chen et 
al., 2014; Mukherjee et al., 2016). Glioma stem cells divide asymmetrically under 
the guidance of cell polarity complexes that control the proper apical and basolateral 
polarization and cell division, a process that was originally identified in Drosophila 
and later confirmed for the mechanism driving differentiation in human glia for 
members of the Hugl-1/Llgl-1 complexes (Prehoda, 2009). We recently developed a 
neurogenic brain tumor model by impairing asymmetric cell division through the 
loss of function of lethal giant larvae (lgl) the Drosophila orthologue of Hugl-1, in 
the type II NBs of the central brain (Paglia et al., 2017). In our model, PI3K 
activation mimics PTEN loss of function and hampers Lgl localization at the apical 
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membrane by aPKC cortical recruitment (Paglia et al., 2017). These data connect 
the function of HUGL-1 in the maintenance of glioma stem cells with the loss of 
function of the tumor suppressor PTEN (Gont et al., 2013) and together with those 
in glioma (Read et al., 2009) show a conserved function for PI3K and EGFR 
overexpression in these tumors recapitulating many features of the neurogenic 
subtype of human glioblastoma. Inhibition of PI3K/Akt activity is currently used as 
a therapy in GBM (Zhao et al., 2017).  
Other brain tumors such as oligodendrogliomas, that account for 10% of all cancers 
of the central nervous system, are characterized by mutations in the capicua (cic) 
gene (Bettegowda et al., 2011), a conserved transcriptional repressor that regulates 
MAPK effector genes downstream of receptor tyrosine kinase (RTK) (Simon-
Carrasco et al., 2018). The development of correct animal model also for these 
tumors will be essential to develop specific treatments that can tackle these different 
brain tumors in vivo.  
 
4.3 The paradigm for angiogenesis  
 
In the fruit fly, the circulatory system is open, the heart pumps the hemolymph into 
the body cavities and the exchange of gases takes place directly within the organs 
(Medioni et al., 2009). Moreover, Drosophila is equipped with a complex branched 
system of interconnected tubules that is responsible for the oxygen transport, the 
tracheal system,  an organ that is comparable in structure and function to the 
circulatory system of mammals (Affolter et al., 2009). In Drosophila’s epithelia, the 
induction of clones bearing lgl, RasV12 mutations identified how tumors are able to 
recruit vessels to oxygenate the growing mass (Calleja et al., 2016; Grifoni et al., 
2015). These tumor cells showed ectopic expression of Bnl (branchless), the 
Drosophila homolog of Fibroblast Growth Factors (FGFs,), and suffered from 
oxygen shortage (hypoxia). In addition, it was observed a trans-differentiation of 
tumor cells into pseudo-tracheal cells with and the formation of new vessels, 
mimicking human FGF-mediated vascularization in cancer (Grifoni et al., 2015).  
Cell under hypoxia condition changes their cellular metabolism to favor growth, 
particularly in solid tumors (Pavlova and Thompson, 2016; Vander Heiden and 
DeBerardinis, 2017). Interesting studies in flies showed how reduction of the SCF 
(Skp/Cullin/F-box)-type ubiquitin ligase Ago, homolog of human Fbw7, increased 
tracheogenesis through up-regulation of the hypoxia-inducible transcription factor 
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Sima/dHIF and of its target, the FGF ligand Bnl (Mortimer and Moberg, 2013). 
Fbw7 is known to inhibit tumor growth by targeting proteins to the proteasome 
pathways, and is mutated in a wide range of primary human cancers, thus data 
suggests that its role as a tumor suppressor may be conserved also in the modulation 
of HIF-regulated angiogenesis in the tracheal system of the fly (Mortimer and 
Moberg, 2013). This process of neo-tracheogenesis is now considered a novel cancer 
hallmark in fly, which may help to explore the relation between angiogenesis and 
tumor growth in humans (Herranz et al., 2016) (Figure 3). 
                                      
  
Figure 3: Cancer cells form branched and tubule-shaped structures (reproduced from (Grifoni 
et al., 2015) with permission). (a) An imaginal wing disc bearing lgl4, RasV12 clones induced in a 
wild-type background. (b-b”) Magnifications of the central region squared in (a). Migrating tumor 
cells (GFP) are positive for the junctional marker aPKC (white) and secrete MMP1 (red). The 
reconstruction along the z-axis shown in the upper part of the magnified images reveals a tubule-
shaped structure encircling a lumen, indicating these cells are forming tracheal-like structures. 
 
 
4.4 Lung cancer  
 
Lung cancer is a major cause of death in the world, and the standard therapeutic 
strategy used is chemotherapy because target therapies only decrease tumor growth 
and result in high toxicity. Recently, a new Drosophila lung cancer model was 
62 
 
developed exploiting the tubular structure of the tracheal network (Levine and 
Cagan, 2016), and considered functionally and anatomically comparable to the 
vertebrate airways (Andrew and Ewald, 2010). Both in Drosophila and mammals, 
airways is formed by interconnected branches that depends on the secretion of 
Bnl/FGFs by the neighboring cells (Ghabrial et al., 2003; Grifoni et al., 2015). Using 
a binary system, RasV12 was ectopically expressed specifically in the tracheal cells 
while downregulating PTEN, a negative regulator of the PI3K/AKT signaling 
(Hafen, 2004; Ortega-Molina and Serrano, 2013). As a result, the cells of the tracheal 
branches over-proliferated to form tumors that ultimately killed the animals (Levine 
and Cagan, 2016). This model was successfully used in a screen for chemical 
compounds approved by the Food and Drug Administration (FDA), which resulted 
in the identification of several compounds able to reduce cell over-proliferation and 
to improve tracheal physiological functions (Levine and Cagan, 2016), further 
highlighting the strong potential of the use of fruit fly models for cancer-related 
chemical screens 
 
4.5 Prostate and thyroid cancer  
 
The prostate is an exocrine gland of the male reproductive system responsible for 
the maturation and production of the seminal fluid, with its activity depending on 
androgens mostly produced by the testis. During organogenesis, the differentiation 
of the prostate’s epithelium occurs along with that of stroma and depends on the 
complex coordination of many transcription factors and hormones that control the 
maturation of the quiescent organ (Toivanen and Shen, 2017). The adult prostate 
epithelium has a low turnover rate and its hyperplasia characterizes the majority of 
benign prostatic tumors. On the contrary, adenocarcinoma of the prostate is an 
aggressive tumor that rapidly progresses to a metastatic stage that can be partially 
blocked by androgen therapy (Shiao et al., 2016). Studies on flies’ male accessory 
gland revealed many parallels with the physiology of human prostate epithelium 
(Wilson et al., 2017), i.e. a genetic screen using the Drosophila accessory gland 
identified genes that promote growth and migration of the secondary cells as 
homologs of genes expressed in human prostate cancer (Ito et al., 2014).  
Like in human prostate, Drosophila’s accessory gland presents a secondary layer of 
epithelial cells that continue to proliferate; this homology allowed the development 
of models that mimic tumors of endocrine origin, including human prostate and 
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thyroid adenomas (Das and Cagan, 2013, 2018). For example, the multiple 
endocrine neoplasia type 2 (MEN2) syndrome, is characterized by different mutant-
translocations involving the RET genes that result in multiple cancer phenotypes, 
including pheochromocytoma, parathyroid adenoma and the aggressive medullary 
thyroid carcinoma (MTC) (Das and Cagan, 2013). A recent study demonstrated that 
the papillary carcinoma of the thyroid (PTC), also caused by another genomic 
mutations of RET gene, can be profitably studied using the accessory gland of 
Drosophila to delineate and understand the mechanisms that characterize PTC in the 
context of the whole animal, including the relationship between tumor and normal 
cells in an environment that mimics tumor of endocrine origin in humans (Levinson 
and Cagan, 2016).  
The prostate epithelium is characterized by the abundance of exosomes, 
microvesicles secreted from the endosomal multivesicular body (MVB) that fuse 
with sperm to modulate its activity  and protect its homeostasis (Wilson et al., 2017). 
The exosomes are particularly relevant in cancer biology for their implication in 
tumor progression and survival, since they deliver survival factors, metabolites and 
miRNAs, that help creating a favorable microenvironment for cancer growth; in 
addition they also favor drug-resistance by activating mechanisms that favor the 
elimination of toxic chemicals such as chemotherapeutic products (Namee and 
O'Driscoll, 2018; Ruivo et al., 2017). Since the accessory gland has a similar 
structure as the prostate epithelium, characterized by the abundance of exosomes, it 
could be an optimal model to better study exosome biology in tumors of endocrine 
origins 
 
5.0 Liquid tumors 
 
The signaling pathways regulating blood cell differentiation are conserved from 
Drosophila to humans (Jung et al., 2005; Lebestky et al., 2003). In addition, fly 
macrophages originate via self-renewal from progenitor cells localized in the lymph 
gland, a specialized hematopoietic organ that can be compared to the hematopoietic 
stem cell niche of the mammalian bone marrow (Krzemien et al., 2007; Mandal et 
al., 2007). These similarities with vertebrate hematopoiesis outline the utility of 
using fly models to elucidate the basic mechanisms of hematopoietic differentiation 
and homeostasis responsible for severe diseases, including leukemia. Drosophila has 
already been used to study Acute Myeloid Leukemia (AML), a widespread form of 
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leukemia, and to identify the genes responsible for the disease. AML1 is a 
transcription factor, responsible for activating myeloid differentiation, which has a 
counterpart in the fly (Sinenko et al., 2010). In vertebrate tumors, the fusion of 
AML1 with the repressor ETO inhibits the differentiation of the multilineage 
progenitor cells, while their proliferation is activated, leading to AML. Interestingly, 
AML1 fused with ETO in Drosophila also causes the inhibition of hematopoietic 
cell differentiation, confirming that the fly is a good genetic model to study the 
mechanisms that drive leukemia in humans (Osman et al., 2009; Sinenko et al., 
2010). Myeloproliferative neoplasms (MPNs) have also been reproduced in the fly 
through gain-of-function mutations in the JAK pathway, finding a role for the 
downstream effector of the SWH pathway Yki in priming the expansion of 
Drosophila blood cells, which undergo malignant behavior following JAK 
activation (Anderson et al., 2017). 
6.0 Cancer and immune system  
Inflammation in tumor development acts as "tug and war" since it may promote 
survival of tumor cells by favoring angiogenesis, by reducing the natural immune 
responses and by altering responses to chemotherapeutic agents (Mantovani et al., 
2008; Wu and Zhou, 2009). The inflammatory response of cancer cells has been 
attributed to a response of the immune system to eradicate the tumor, but it can also 
be seen as a way to provide growth and survival, as inflammation contributes to 
genomic instability by releasing cytokines and through production of reactive 
oxygen species (ROS) that may induce genetic and genomic alterations (Negrini et 
al., 2010). Normal cells detect and repair DNA damage, ensuring the maintenance 
of the correct number of chromosomes and tissue homeostasis, instead often cancer 
cells have increased mutation-rates leading to high chromosomal instability (CIN) 
that triggers aneuploidy and advances tumorigenesis (Negrini et al., 2010). 
Chromosomal instability is a process conserved also in Drosophila, and it was 
shown to contribute to the invasive behavior of epithelial cells, with a mechanism 
called “compensatory proliferation” activated to counteract CIN-induced cell death 
(Benhra et al., 2018; Clemente-Ruiz et al., 2016).  
The mechanisms controlling cancer immune response are somehow conserved also 
in flies as studies in Drosophila have shown that infiltration of macrophages (called 
hemocytes) in cancer cells requires the activation of the JAK-STAT, JNK, TNF-α, 
and Toll/Imd/TLR signaling pathways (Bangi, 2013). Of particular interest is TNF-
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α that plays an important role in controlling apoptosis and the inflammation 
processes (Ham et al., 2016). TNF-α in tumors has distinct and overlapping functions 
to promote tumor growth and proliferation and to activate cell death, functions that 
are mainly mediated by the activation of TNFR1 that is ubiquitously expressed while 
TNFR2, mainly expressed on immune cells, is less well understood. Thus these 
opposite signaling pathways activated by TNF signals depend on the adaptor 
complexes recruited by the receptors and by the cellular context, and they may create 
a problem for the development of therapeutic strategies that target TNF signaling in 
tumors (Ham et al., 2016). In Drosophila the sole TNF-α, called Eiger (Egr), binds 
two receptors called Wengen (Kanda et al., 2002) and Grindelwald (Andersen et al., 
2015), the latter shown necessary for the growth of RasV12/scribble-/- tumors 
(Andersen et al., 2015). An interesting mechanism links the possibility that ROS, 
induced by stress or local inflammation, triggers Egr expression in the hemocytes, 
to control JNK signaling, in a phenomenon called Apoptosis-Induced Proliferation 
(AIP), a sort of compensatory proliferative response of the epithelial cells that 
responds to cues from local “activated” hemocytes (Fogarty et al., 2016). Other 
studies highlighted the role of hemocytes in the interplay between inflammation and 
cancer, i.e. using a classic cancer model that recapitulates the hallmarks of epithelial 
cancer cells (Rasv12/scribble-/-), it was shown that cancer cells induce hemocyte’s 
recruitment and proliferation in vivo by activating JNK signaling to cause the 
expression of JAK/STAT cytokines (Pastor-Pareja et al., 2008). Using a similar 
model it was shown that Egr expression was higher in the hemocytes derived from 
cancer animals, and that its activity was necessary to stimulate invasive migration of 
tumor cells (Cordero et al., 2010). On the contrary, Egr acts as a tumor suppressor 
to drive apoptosis in cancer cells upon activation of Toll/NF-ĸB signaling by the fat 
body (adipocytes) in response to the secretion of Egr by the circulating “activated” 
hemocytes (Parisi et al., 2014). Work using allograft transplantation experiments, 
identify also a function for the hemocytes in tumor initiation, that is independent on 
Eiger, but relays rather on the activation by external stimuli (i.e. CIN, abnormal 
growth) of JNK pathway and on the complex of non-autonomous and autonomous 
signals between tumor cells and those composing the tumor microenvironment; a 
similar mechanism has been proposed in vertebrates suggesting a conserved 
response for JNK signaling in fly to control initial tumor growth  (Muzzopappa et 
al., 2017). . 
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In summary, all these data suggest the existence of conserved mechanisms between 
the immune and tumor cells in flies that may recapitulate some of the most 
evolutionary conserved aspects described in cancer cells. 
 
7.0 Cancer and lipid metabolism, obesity 
 
In tumor biology, evidences highlight the relevance of lipid metabolism in 
influencing tumor growth (Katheder and Rusten, 2017; Weber et al., 2017). In this 
context, a recent role was identified for adipose triglyceride lipase (ATGL) whereby 
it hydrolyzes triacylglycerols into fatty acids (FAs) that may act as signaling 
molecules to induce growth both cell autonomously and in neighboring cells 
(Walther and Farese, 2012). The contribution of ATGL to cancer growth is 
controversial, indeed several studies showed that its depletion reduced proliferation 
in colorectal cancer cells and in non-small-cell lung carcinoma (Ou et al., 2014; 
Zagani et al., 2015), and in breast and pancreatic carcinoma its upregulation 
contributed to tumorigenesis (Grace SA et al., 2017; Wang et al., 2017). On the 
contrary, lack of ATGL favored pulmonary neoplasia in mice and in few human 
tumors ATGL expression was found reduced highlighting the complex role of lipids 
in tumorigenesis (Al-Zoughbi Wael et al., 2016). Cancer cells activate de novo 
lipogenesis by upregulation of key enzymes in lipid metabolism, some of which, 
such as AcetylCo-A Lyase (ACLY), AcetylCo-A Carboxylase (ACC) and Stearoyl-
CoA desaturase-1 (SCD), are targets of pharmacological inhibitors to decrease 
cancer proliferation (Peck and Schulze, 2016; Stoiber et al., 2018; Zaidi et al., 2012; 
Zu et al., 2013). Recent work associated the mechanism of lypolysis with the 
induction of autophagy, a mechanism used by the cells to re-cycle part of their 
cytoplasm or cellular content to survive when nutrients are reduced (Dall'Armi et al., 
2013). The relevance in cancer of the link between lipids and autophagy was shown 
when ATGL-mediated lipolysis in a peritumoral area, increased autophagy and 
tumor survival using a non-autonomous mechanisms (Gnerlich et al., 2013; 
Martinez-Outschoorn et al., 2011). Interestingly, we observed that Myc in 
Drosophila induced autophagy in the fat body and this was enough to enhance 
survival of the whole animals upon starvation (Parisi et al., 2013). We linked this 
effect with the ability of Myc to increase desat1, a Stearoyl-CoA desaturase-1 
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(SCD1) key enzyme in the synthesis of lipids, that we found co-expressed with Myc 
in human prostatic tumors (Paiardi et al., 2017). 
Metabolic disorders and obesity are associated with cardiovascular disease and type 
II diabetes (T2D), however numerous cohort studies reported that overweight people 
are more likely to develop certain types of cancer including endometrial, breast, 
liver, and ovarian cancer (Cancer, 2012; Chen et al., 2012; Dougan et al., 2015; 
Hirabayashi, 2016; Riboli, 2014; Wang and Xu, 2014). Obese people have often 
increased levels of circulating hormones like insulin that has been associated to 
higher levels of IGF-1 in colon, kidney, prostate and endometrial cancer (Gallagher 
and LeRoith, 2015; Roberts et al., 2010). Another hormone, leptin, a cytokine 
produced by the adipocytes to control satiety in a signaling circuit of the brain, has 
also been found up-regulated in tissues from obese people, particularly in women 
post-menopause, and increased levels of leptin have been associated with higher 
incidence of breast and other tumors (Ray, 2018). The adipose tissue produces pro-
inflammatory cytokines including IL-6, IL-8, IFNγ and TNF-α among others 
(Arango Duque and Descoteaux, 2014; Scheller et al., 2011), and their over-
production in fats from obese, activates the infiltration of macrophages into the 
adipose tissue inducing a low level of chronic inflammation or adipocyte tissue 
macrophage infiltration called ATM (Kuroda and Sakaue, 2017; Lafontan, 2014). 
This low level of inflammation increases the levels of ROS and induces DNA and 
protein damage that may increase the risk of cancer (Lafontan, 2014; Mraz and 
Haluzik, 2014). The role of the inflammatory response to combact infection and 
tissue injury, through the activation of the immune cells, is conserved also in 
Drosophila’s circulating hemocytes (Lemaitre and Hoffmann, 2007), where most of 
the signals activated in the fat body results also in ROS production (Dionne, 2014; 
Vlisidou and Wood, 2015). Indeed, we showed, using a genetic model that harbors 
an inflammation state in the fat body of larvae that mimic ATM, that reduction of 
ROS, using exogenous anti-oxidants components like flavonoids and anthiocianins, 
decreased hemocyte’s migration and JNK activation in the cells of fat body (Valenza 
et al., 2018), suggesting that the converging signaling between the fat body and 
hemocytes on lipid metabolism and ROS/cytokines in response to stress is conserved 
also in Drosophila. 
 
8.0 Cancer stem cells  
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Cancer stem cells (CSCs) have more features than tissue stem cells because they are 
able to initiate the tumor growth and fuel its maintenance and metastasis (Kreso and 
Dick, 2014; Malanchi et al., 2011). In addition, CSCs are highly resistant to 
conventional therapy, both radiation and chemotherapy, and they are responsible for 
the recurrence of disease (Mueller et al., 2009). Since the mechanisms underlying 
the ability of stem cells to support cancer progression are still unclear, Drosophila 
is convenient to use as it provides many tools for genetic and molecular 
investigations. Adult stem cells are required for tissue homeostasis and repair after 
injury and in adult flies, populations of stem cells are present in the posterior midgut, 
testis, and ovarian follicle rendering it again a good system to dissect these stem cell 
programs (Hou and Singh, 2017). Drosophila was used to better understand the 
functions of the centrosome and microtubule-organizing center (MTOC) in the 
division of stem cells (Tillery et al., 2018). Drosophila and mammalian stem cells 
are similar and they are regulated by homologous signals corroborating the use of 
the fly in this field of tumor biology. CSCs can arise from normal stem cells whose 
long lifespan favors the accumulation of genetic mutations responsible for the 
malignant phenotype. The progression from normal progenitors to stem-like cancer 
cells was first explored in leukemia, although nowadays we know that several solid 
tumors such as brain, breast, lung and colon cancer originate from cells with stem 
features (Krivtsov et al., 2006). Several Drosophila models of stem cell tumors are 
now available, and a drug screening was successfully carried out highlighting several 
compounds active on the signaling promoting cancer growth (Markstein et al., 
2014).  
 
9.0 Drosophila cancer models for the identification of therapeutic drugs 
Therapeutic drug discovery requires chemical screening, a procedure allowing for 
the identification of potential new drugs. The spread of sequencing, automation, and 
miniaturization has made High Throughput Screening (HTS) the leading contributor 
to early-stage drug discovery. HTS consists of random screening of chemicals to 
find an affinity for a specific protein or biological activity characteristic of a 
disorder. Once identified in vitro, the compounds need to be validated in vivo to 
assess efficacy and toxicity during a long and expensive period of drug development. 
The high throughput assays depend on the existence of a specific target, assuming 
an in depth understanding of a disease that is not always available. Phenotype 
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screening is an eligible option when the knowledge about the mechanisms 
underlying a disease process is not well defined. It is a process by which small 
molecules are screened for their effect on the phenotype in cells, tissue or whole 
animals, where a more physiological environment better describes the 
pharmacokinetics and toxicological effects of a drug. The great availability of 
genetic tools and the low cost of maintenance makes the fruit fly an ideal to model 
to study human diseases including cancer, in fact the fly has considerably 
contributed to understand tumor biology.  
Chemical screens have been successfully performed in Drosophila for several 
disorders affecting the central nervous system, kidney and metabolism (Gasque et 
al., 2013; Hofherr et al., 2016; Whitworth et al., 2006), as well as for a type of thyroid 
cancer, the multiple endocrine neoplasia type 2A and 2B (MEN2) (Vidal et al., 
2005). Regarding cancer, JAK- STAT, APC, Wnt, Notch and other signaling 
molecules, deeply characterized in Drosophila and shared with humans, are precious 
for cancer drug development. The availability of Drosophila models for multiple 
cancer types makes pharmacological screens possible against several drugs that aim 
to restrict proliferation and metastasis. The identification of anticancer compounds 
is possible using the adult fly, but also larvae, embryos and cells. The combined 
effect of anti-cancer drugs with radiation has been investigated in Drosophila larvae, 
producing similar findings to those observed in human cancer cells (Edwards et al., 
2011). Moreover, Drosophila avatars, consisting of patient-specific tumors modeled 
in transgenic flies, are very promising for personalized medicine. Drosophila and 
other small model organisms are helpful to quickly analyze the mode of action of 
several active compounds in vivo, nevertheless mammalian models are indispensable 
in the successive phase of drug development to define important pharmacokinetic 
parameters such as absorption, distribution and metabolism. 
 
 
10.0 Discussion 
 
The communication between tumor cells and their microenvironment is largely 
implicated in neoplastic growth, hence the substantial difficulty to recapitulate the 
features of malignant transformation in cellular systems. Cancer research needs in 
vivo investigations, and the use of model organisms contributes to answer this 
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request. In this review we described most relevant approaches in Drosophila, used 
to explore cancer mechanisms and therapeutics that contribute to our understanding 
on tumor initiation and progression. In spite of some limitations, because of the 
anatomical differences between flies and humans, the use of Drosophila’s cancer 
models has been fundamental to understand some basic processes that regulate 
human cancers, such as the competitiveness of cancer stem cells (CSCs), the 
importance of tumor microenvironment, cancer cachexia, drug resistance and tumor-
associated vasculogenesis, which was recently found to be functionally conserved in 
fly’s cancer. Additional cancer hallmarks such as genomic instability, resistance to 
cell death, cell metabolism reprogramming, tumor-promoting inflammation and 
evasion from the immune system, have been studied and extensively characterized 
in Drosophila. Finally, although the evolutionary difference between Drosophila 
and humans certainly represents a restriction to the use of the fruit fly in drug 
discovery and development, phenotypic screenings have proven relevant to identify 
potential drugs that would elude the classic screens in the absence of targets. 
Drosophila is also offering a significant contribution to the investigation of 
organotypic cancers, since despite the evident differences at the macroscopic level, 
organ cells and functional units are usually well conserved at the biochemical and 
structural levels respectively. This conservation allowed to develop thyroid, lung, 
prostate, gut, brain and blood cancer models starting from the most characteristic 
genetic lesions found in the same human cancers. These models, as described in the 
review, are greatly helping in dissecting the contribution of specific molecular 
pathways to the final cancer phenotype. Given the heterogeneous nature of 
mammalian solid cancers, new strategies are being developed to decipher cancers at 
single-cell resolution. The international Drosophila community has always been 
engaged in the development of novel, sophisticated genetic tools, which allowed in 
the last 30 years to revolutionate functional gene analysis. For this reason, we 
anticipate that the use of the fruit fly will move fast into the field of precision 
medicine, contributing to seminal findings in this new era of cancer research. 
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Chapter 5 
 
Conclusions and future perspectives 
 
During my PhD, I worked on an innovative project using Drosophila models to study 
human diseases. 
 
The aim of this project was to characterize a new genetic model to study obesity with 
particular emphasis of the role of the hemocytes, the Drosophila’s macrophages, and 
their migration into the fat body, Drosophila’s adipose tissue, as a model mimicking 
chronic inflammation in obese people, and to analyze the effect of important 
compounds such Anthocyanins in the hemocytes infiltration in the obese Drosophila’s 
larvae fat body. 
 
The incidence of obesit drammatically grew in worldwide and it has become a global 
problem. Data reported by The World Health Organization (WHO) are alarming, in 
which the prevalence of childhood obesity increases with the risk to develop other 
pathologies (53, 145). The fruit fly, Drosophila melanogaster, is an excellent model 
for studying nutrient-sensor pathways and metabolic dysfuctions. 
Recent studies performed on Drosophila obese models show that the molecular 
mechanisms that regulates the metabolic functions and processes are conserved 
between humans and flies (78).  
Drosophila fat body is functionally analogous to the mammalian adipose tissue and 
liver, indeed the fly fat body contributes to the maintenance of energy storage in the 
form of lipids and glycogen, and it is involved in obesity-related disorders (146, 147). 
Furthermore, the Drosophila fat body is an organ that serves the roles of the immune 
system with recruitment of the hemocytes, equivalent to mammalian macrophages 
(107). 
 
In this work, I demonstrated, for the first time, a strong evidence of the potential use of 
plant’s derived Anthocyanins in the diet to control chronic inflammation and provide 
a link to the oxidative stress that characterizes the adipose tissue in obese animals. I 
was able to evidence the ability of Anthocyanins to decrease in vivo the 
phosphorylation of JNK/SAPK p46 stress kinase, thus providing a new insight into the 
mechanism of phenolic compounds in the treatment of inflammation in adipose tissues, 
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a field of current study since the lack of a better knowledge of the mechanisms that 
regulate or control ATM in pathologies such as obesity and metabolic disorders. 
At the same time, Anthocyanins are able to activate antioxidant detoxifycation factors 
such as Nrf2. These finding suggest that Anthocyanins can regulate the inflammaroty 
responses, therefore can be considered as anti-inflammatory agents.  
Furthermore, I evaluated the antioxidant power of Anthocyanins, in particular, I 
examined how the Anthocyanins extract modulates GST D1 mRNA expression level 
in our model. 
Therefore, the mainly action mechanism of Anthocyanins in the cellular defence 
against inflammation-induced oxidative stress could be the regulation of the 
CncC/Keap-1 pathway, one possible way to increase the activity of GST D1, decrease 
JNK pathway activation and to fight the excess of ROS. 
The present study confirms the great importance of Anthocyanins consumption and 
provides new insights into the mechanism through which these phenolic compounds 
regulate the specific signaling pathway involved in the different cellular processes. 
 
 
In the future, we need to continue these experiments in order to better understand the 
mechanism that links Anthocyanins to antioxidant detoxifycation factors such as Nrf2 
to discover new possible signals involved in inflammatory and oxidative process. 
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